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ABSTRACT 
 
 
 
 With the advent of sophisticated genetic, biophysical and in silico technology an 
enormous amount of information is being generated regarding the structural, biochemical and 
physiological aspects of proteins. Tertiary protein structural domains are assumed to be features 
of proteins whose bio-historical relationships can be traceable over relevant evolutionary space. 
The phylogenetics of protein domains, including their genesis, duplication, combination, 
selectively derived loss and potential horizontal capture to derive novel functional 
rearrangements, are of great interest to molecular evolutionists. Evolutionary and bioinformatic 
analyses of a considerable collection of variable protein primary, secondary, tertiary, quaternary 
and biochemical structures has established the principle that, from a functional perspective, 
many, if not most, proteins are evolutionarily dependent on the functional capacity of readily 
defined and identifiable, globular components defined as "domains". Therefore, it is reasonable 
to infer that specific secondary and tertiary folds, or arrangements, represent functional 
phenotypic characters that can be analyzed to provide insights into the evolutionary history of 
any given protein domain. The evolution of proteins, at the domain level, has a significant impact 
iv 
on the overall functionality of metabolic pathways in general. Therefore, insights into the 
evolutionary trajectories of protein domains have the potential to inform the understanding of 
every aspect in which any given protein has a role of functional significance including, but 
certainly not limited to basic metabolic equilibrium, potential physical compromise at the 
phenotypic level, and deeper insights into corruptions that often lead to metabolic dysfunction 
and potential progression to full blown disease states. The prime focus of this study is to 
investigate the evolutionary relationships of proteins, across all Kingdoms of life, that contain 
within their tertiary phenotypic structure the 4-bladed β-propeller domain (the "Hemopexin" or 
"PEX" domain), towards illuminating the biophysical and biochemical significance of this 
specific domain's impact on protein functionality. While the phylogenetic relationships of entire 
proteins that have PEX domains is relatively straight forward, the mutational accumulation in 
gene sequences that lead to the tertiary structure of the PEX domain itself seems to have partially, 
if not entirely, obscured the evolutionary history at the domain level.  
 The phylogenetic analyses presented here allow for several novel conclusions. First, this 
research demonstrates that a derived primary amino acid sequence in mammalian Hemopexin 
proteins (the JEN-14 epitope) represents a functional synapomorphy at the molecular level. 
Secondly, that there is substantial evidence for horizontal gene transfer of PEX domain proteins 
into specific Fungi. Additionally, there are no proteins containing a PEX domain in Kingdom 
Archaea. Lastly, it argues that the PEX domain itself represents an evolutionary “spandrel” 
(sensu Gould and Lewontin) with specifically derived functions existing around a core, preserved 
structural architecture. 
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CHAPTER 1 
STRUCTURAL ANALYSES OF THE HEMOPEXIN PROTEIN AS A TOOL TO INFER 
THE EVOLUTION OF FUNCTIONALITY BETWEEN THE PEX DOMAIN 
CONTAINING PROTEINS 
 
Introduction 
 From very early in the advent of modern genomics, questions were raised about the 
observation that many structures at the molecular level, while appearing to be architecturally 
conserved, were not correlating well with the underlying primary amino acid sequences of 
the proteins in which they were found. This is notably true when considering the myriad 
protein domains comprised of the β-propeller fold motif.  These domains are constructed by 
the sequential arrangement of "blades" that are each a single, anti-parallel, β-sheet 
component, that when combined, make up the propeller configuration. The domains 
(propellers) may consist of anywhere from 4-8 blades inclusive 
1-5
; and there is a single 
known 10-bladed propeller found in a type I membrane glycoprotein named sortillin, that 
functions in intracellular sorting and endocytotic processes in neurons 
6
.  Structural models of 
several protein domains with increasing number of β-propeller blades are available in 
Research Collaboratory for Structural Bioinformatics Protein Data Base (RCSB PDB - 
henceforth PDB) 
7
 Figure 1. For more detailed information on these representative proteins 
see Table A1, Appendix A. 
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Figure 1.   Representative proteins with known variable numbers of β-propeller 
 structural domains. Designations represent PDB ID numbers for each structure. 
 
Hemopexin - N-Domain;  
4-bladed 
Tachylectin-2;  
5-bladed 
RACK-1;  
7-bladed 
1-RWL;  
6-bladed 
4ZOX;  
8-bladed 
3F6K;  
10-bladed 
3 
 These analyses will focus exclusively on the evolution of the 4-bladed β-propeller 
(PEX) domain, exemplified by the dual arrangement seen in the tertiary structure of the 
Hemopexin (HPX) protein. One principle objective of this study is to use phylogenomic 
analyses to determine the evolutionary relationship of the PEX domain containing proteins in 
hopes of uncovering patterns that will help us gain insights into how the structural constraints 
of the 4-blade β-propeller domain molecular scaffolding has given rise to such variable 
biochemical functionality. If enzymatic, the active site is often found in the cleft formed in 
the center of the propeller by loops connecting the successive four-sheet motifs, but the 
purposes vary considerably between proteins. The evolution of these highly divergent 
molecular tasks associated with the physically stable architecture of the PEX domain is 
defined herein as Functional Hyperplasticity. 
 
Hemopexin 
 
 HPX, a glycoprotein found in the blood plasma of many vertebrate organisms, has 
been shown to have the highest known binding affinity for heme with a measured Kd <10
−12
 
M 
8
. The protein is also known as β-1B-glycoprotein, and is a single polypeptide chain of 
~439 residues, with a molecular mass of approximately 63 kD. 
 Many studies have shown that the primary function of Hemopexin is to sequester 
unbound heme released into the plasma from the breakdown of hemoglobin. The crystal 
structure of Hemopexin has been solved and the molecule consists of two structurally similar 
N-terminus and C-terminus β-propeller domains of about 200 residues in length, joined by a 
flexible, unstructured linker peptide 
9
. This linker region is known to be part of the heme 
4 
binding site. The gene that codes for Hemopexin (HPX) has been shown to have numerous 
sequences identified as recognizable hemopexin amino acid repeats (HX) in the primary 
structure of the protein. The Fe (III) of the heme is coordinated by 2 histidine residues (in 
Homo sapiens NP_000604.1 H213 and H271) and further stabilized by a host of noncovalent 
interactions provided by a number of invariant aromatic and basic residues 
9
. 
 Hemopexin has been shown to play a part as a reactant induced after inflammation 
during the acute phase of the innate immune response in animals but not in humans 
10-12
. It is 
synthesized primarily in the liver, although it can also be expressed in peripheral nerves, the 
central nervous system and the retina 
13
. Its principal function is to capture heme freed from 
the breakdown of hemoglobin and subsequently released into the plasma. The need to capture 
and remove this free heme is vital due to biochemical properties which lead to cell membrane 
interference and production of free hydroxyl radicals, both properties that can have damaging 
effects on cellular health and functionality 
14, 15
.  Hemopexin has been shown to help prevent 
heme influenced oxidative stress, and to reduce the probability of iron loss associated with 
heme binding 
11, 16, 17
. 
 Additionally, the removal of free heme from circulation reduces the availability of 
iron that could potentially be used as a resource by invasive pathogens 
18
. Several studies 
have shown that in concert with operating as a plasma heme transporter, hemopexin 
functions variously in several additional, health-related pathways. These include, but are 
certainly not limited to, blood iron homeostasis, generalized antioxidant protection, assisting 
in the regeneration of damaged nerve tissue, and gene expression modulation 
19
. 
 After binding the heme, the heme-hemopexin complex is then transported to the liver 
where is removed from circulation through a receptor-mediated endocytic process 
20
. Once 
5 
sequestered in the liver cells, the heme is released and degraded by Heme Oxygenase. The 
freed iron is then stored, used in regulation, or recycled to the bone marrow for inclusion in 
newly synthesized erythrocyte precursors 
20, 21
. 
 In addition to the responses to pathological conditions, a considerable amount of 
research has indicated that hemopexin constitutively regulates normal physiological iron and 
heme homeostasis
22
. The heme-hemopexin complex also initiates a variety of important 
signaling cascades including Protein Kinase C (PKC), Stress-activated Protein Kinase (also 
known as JNK), Mitogen-activated Protein Kinase 3 (a.k.a. ERK) and Nuclear Factor kappa 
B (NFκB) several of which are known to regulate transcription factors such as Metal 
Regulatory Transcription Factor 1 (MTF1), and Nuclear Factor, Erythroid 2 like 2 (a.k.a. 
Nrf2). These transcription factors, in turn, activate genes whose protein products help to 
protect cells from further oxidative stress 
23
.   
 The crystal structure of HPX has been solved and the molecule consists of two 
structurally similar 4-bladed, N-terminus and C-terminus β-propeller domains joined by a 
flexible unstructured linker peptide 9. This linker region is known to be part of the heme binding 
site and provides one of the two histidine ligands necessary to coordinate the heme iron.  
Previously delineated HPX repeat locations were accessed and mapped onto the crystal structure 
using PyMOL. Other sequences of particular interest were also mapped.  
 Structural mapping has revealed some interesting associations between the functional 
motifs and tertiary structure of these domains and these relationships may have implications 
for understanding the evolution of the hemopexin protein (for which the domain is named, 
but in this work, for clarity, referred to as the PEX domain). There is additional potential to 
elucidate the phylogenetic relationships among several other classes of animal proteins that 
6 
contain HPX repeats that comprise PEX domains, including the myriad Matrix 
Metalloproteinases (MMPs), Proteoglycan-4 (PRG4) and Vitronectin (VTN). All these 
proteins are associated with the extracellular matrix of multicellular animals, and research 
has implicated many of them in immune system dynamics 
24
. This analysis is a primary 
outcome of the current study. 
 
PEX domains outside of HPX 
 
 The 4-bladed β-propeller (PEX) domain has been discovered to also exist in a variety 
of proteins found in taxa other than Animalia. In Plantae, several proteins from leguminous 
members have been discovered to contain PEX domains including lentils (Lens culinaris), 
chick pea (Cicer arietinum), grass pea (Lathyrus sativus), and cow pea (Vigna unguiculata) 
25-28
. A PEX fold has also been found in rice (Oryza sativa) 
29
. These sequences for non-
animal PEX domains are used in the phylogenetic analyses found in Chapter 2 of this work. 
There are also a number of PEX domains that have been identified in prokaryotic proteins 
30
. 
However, the scope of this work will not encompass inclusion of the prokaryotic forms in the 
analyses with the exception of one chosen to hypothetically help root phylogenies. 
Pertinently, from an evolutionary perspective, this root likely represents horizontal gene 
transfer/capture (HGT/C) by a parasitic-pathogenic organism. This result is a primary 
conclusion of this work (see Chapter 3).  
 In the fungi, a protein with remarkably similar structure to previously described PEX 
domains from both Animalia and Plantae has been described from the oyster mushroom 
7 
(Pleurotus ostreatus) and named ostreopexin 
31
. Other purported PEX domains are also 
included in the broader phylogenies presented in Chapter 3. 
 
Methods 
 
The basic structure of hemopexin  
 
The Human hemopexin protein has a 462 amino acid primary sequence, with a 
molecular weight of ~ 60 kDa. The FASTA file of the primary amino acid sequence for the 
human hemopexin protein was obtained from the National Center for Biotechnology 
Information (NCBI) database 
32
. This file was then imported into the Basic Local Alignment 
Search Tool (BLAST) and analyzed using the nucleotide BLAST function 
33
. Appendix A, 
Table A2 presents sequence comparisons of hemopexin genes and proteins between 
representative animal species.  
 The earliest success at determining the tertiary structure of the PEX domain involved 
crystallization of the C-terminal domain of hemopexin 
34
. Subsequent to that achievement, 
crystal structures for the entire hemopexin molecule, bound to a heme moiety, in both 
glycosylated and de-glycosylated forms were derived. The PDB is a public access repository 
for crystallographic structure analyses of biological macromolecules that has a standardized 
file format (PDB files) 
7
. Each structure is given a unique 4-character alphanumeric 
designation, the PDB ID.  There are two complete structures available for rabbit hemopexin 
in the PDB: 
8 
 1QHU - Mammalian blood serum hemopexin deglycosylated and in complex  
   with its ligand heme 
9
, and 
 
 1QJS - Mammalian blood serum hemopexin glycosylated-native protein and in  
  complex with its ligand heme 
9
. 
 
 For this work, 1QHU was chosen for more detailed structural investigations. The 
PDB ID file for 1QHU was downloaded and imported into PyMOL, a computer based, 3-
dimensional structure visualization program 
35
.  See Figures 2 and 3 below for graphic 
presentations of the entire HPX molecule from various spatial perspectives. 
 
Results  
 
 The molecule consists of two structurally similar (but not identical) N-terminus and 
C-terminus  -propeller domains joined by a flexible unstructured linker peptide, known to 
be the site of heme binding. Visualizations of the tertiary structure of the hemopexin 
molecule was accomplished using PyMOL, an in silico, molecular visualization system 
created by Warren Lyford DeLano 
35
. The structures are shown with the molecule bound to 
its prime ligand, the porphyrin heme, shown in green in all views. 
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Figure 2.   Basic crystal structure of rabbit hemopexin in complex with its ligand, heme. The 
N-terminus of the complex is shown in red, the C-terminus in blue and the heme moiety 
green. 
 
 
 
 
Figure 3.   Views of the N (left) and C (right) termini, showing the 4-bladed β- propeller 
architecture of each domain.  
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Analysis of position of HPX primary sequence repeats within domain structures 
 
 There are several important primary amino acid repeat sequences seen in the 
hemopexin molecule 
36-38
. These include the DAAV/F motif and the WD-repeat. The WD 
repeats form a significant portion of the β-strands of each of the four blades of the propellers. 
The average number of residues in the WD repeats is approximately 43; the various WD 
repeats found in the rabbit hemopexin structure are comprised of from 39 to 45 residues and 
are alternatively referred to as Hemopexin (HPX) Repeats. Table 1 below shows the 8 HPX 
repeats found in the HPX protein primary sequence, color-coded as in the graphical 
representations of the same repeats mapped onto the 3-dimensional structure of the N and C 
termini of the molecule respectively, shown in Figures 4 and 5. 
 
Table 1. Color-coded arrangement of hemopexin repeats in the primary sequence of the       
hemopexin protein. Colors correspond to those showing positioning of repeats on the tertiary 
structural model (Figures 4 and 5). 
 
_______________________________________________________________________ 
 
  MARVLGAPVALGLWSLCWSLAIATPLPPTSAHGNVAEGETKPDPDVTERCSD 
  GWSFDATTLDDNGTMLFFKGEFVWKSHKWDRELISERWKNF 
  PSPVDAAFRQGHNSVFLIKGDKVWVYPPEKKEKGYPKLLQDEFPGI 
  PSPL REWFWDLATGTMKERSWPA 
VGNCSSALRWLGRYYCFQGNQFLRFDPVRGEVPPRYPRDVRDYFMPC 
 
 
  PGRGHGHRNGTGHGNSTHHGPEYMRCS (heme binding “linker” region) 
 
 
  PHLVLSALTSDNHGATYAFSGTHYWRLDTSRDGWHSWPIAHQWPQG 
  PSAVDAAFSWEEKLYLVQGTQVYVFLTKGGYTLVSGYPKRLEKEVGTPHGII 
  LDSVDAAFICPGSSRLHIMAGRRLWWLDLKSGAQATWTELPWP 
  HEKVDGALCMEKSLGPNSCSANGPGLYLIHGPNLYCYSDVEKLNAAKALPQ 
  PQNVTSLLGCTH 
  _____________________________________________________________________ 
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 Each of these repeats is structurally consistent with the "blades" of the 4-bladed β-
propeller, or PEX domain. The architecture of each individual blade consists of three or four 
antiparallel β-strands. The 4 blades, in turn, are connected by short variable length loops and 
space filling α-helices. The connecting regions between strands differ considerably and 
account for approximately half the overall structure of the molecule. Although less 
constrained by structure these loops provide the biochemical features that form the heme-
binding mechanism and are responsible for inter-domain functionality. 
 Recent annotation added to the graphics section for the hemopexin protein (HPX) - 
Homo sapiens, NCBI Reference Sequence: NM_000613.2, shows the positioning of the now 
established eight hemopexin repeats representing the two 4-bladed β-propeller domains of 
the molecule. Until this update it was assumed that the protein only contained 4 repeats, 2 of 
Figure 4.   The N-terminal, PEX 
domain, showing the blade structure 
associated with the 4, tandem 
hemopexin repeats variably colored. 
Blade 1 = blue; blade 2 = violet; 
blade 3 = green; blade 4 = red. 
 
Figure 5.   The C-terminal, PEX 
domain, showing the blade structure 
associated with the 4, tandem 
hemopexin repeats variably colored. 
Blade 1 = forest green; blade 2 = 
raspberry; blade 3 = cyan; blade 4 = 
hot pink. 
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each associated with the double domain structure. In earlier analyses considerable confusion 
was generated by the mistaken omission of the additional 4 repeats subsequently added. We 
have validated the inclusion of these repeats using a domain-based analysis, examining each, 
utilizing PHI-Blast and Blast2 alignments. As a result, the current domain architecture listed 
within the NCBI file for Hemopexin should be considered canonical. However, we note that 
not all putative hemopexin repeats have been thus annotated across NCBI, and our 
phylogenomic outcome suggests that many more such annotations should be appended. One 
conclusion of this study is the identification of the necessity for these annotations and to 
enter them into the appropriate NCBI database upon peer-reviewed publication. 
 The phenotypic evolution of the hemopexin molecule appears to have involved a 
genetically predicated structural duplication leading to the similarity in secondary and 
tertiary architecture of the N and C termini 
39
. Paradoxically, the primary structures of these 
two β-propeller motifs show only a 27% residue sequence identity, and 40% positive 
biochemical identity. However, in spite of this lack of sequence similarity the structures 
superimpose remarkably well (Figure 6). It was this realization that lead to the fundamental 
driving evolutionary question of this investigation, namely, how could a structure with such 
weak primary sequence homology remain so structurally consistent? This, in turn, developed 
into questions of the evolutionary significance of the concept of functional hyperplasticity 
defined as the highly divergent molecular functions associated with the evolutionarily 
constrained physicochemical architecture of the PEX domain. 
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Figure 6.   The N-terminal and C-terminal domains of Hemopexin superimposed, showing a 
very high degree of symmetry with one another despite having relative weak sequence 
similarity. The RMSD for this alignment = 1.009 Å.  
 
 Not surprisingly, the gene coding for hemopexin has been identified in the 
Neanderthal genome, although the current state of annotation the Neanderthal Genome site 
still uses outdated protein domain architecture to identify structural components of the 
peptide sequence 
40, 41
. An annotation and update of the Neanderthal protein will be 
forthcoming using the current understanding of positioning of the PEX domains within H. 
sapiens hemopexin, and their concomitant pexin-repeat sequences. A PSI-BLAST search was 
also performed on the recently released Denisovan Hominin (Homo sapiens ssp. Denisova) 
genome using the Homo sapiens ssp. sapiens sequence for hemopexin (NP_000604.3) as the 
query, but no significant hits were achieved. Given that is most unlikely that this 
subpopulation of humans did not have a gene to code for hemopexin, investigations will 
continue as the Denisovan Genome is uncovered and reported 
42, 43
.  For further discussion 
related to this section, see Chapter 4. 
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CHAPTER 2 
DISCOVERY AND CHARACTERIZATION OF THE JEN-14 EPITOPE AS A 
MOLECULAR SYNAPOMORPHY IN HEMOPEXIN 
 
Introduction 
 Hemopexin (HPX), a glycoprotein in the blood plasma of many vertebrate organisms, 
has been shown to have the highest known binding affinity for heme. HPX belongs to the 
acute phase class of immune reactants and is induced by inflammation. Many studies have 
shown that the primary function of HPX is to sequester unbound heme released into the 
plasma from the breakdown of hemoglobin. The need to capture and remove this free heme is 
vital due to chemical properties that can lead to severe cell and tissue damage, primarily 
through the production of free hydroxyl radicals.  
 An epitope, which binds to a monoclonal antibody designated "JEN-14", is a 22 
amino acid primary sequence located within the HPX repeat 2 containing blade of the N-
terminus of the HPX protein. Hemopexin captures and transports free heme to receptors 
located on the surface of liver parenchymal cells, that are known to be the low-density 
lipoprotein receptor related protein 1 (LRP1, a.k.a. "Cluster of Differentiation-91": CD91), a 
multifunctional receptor which recognizes several ligands including the heme-hemopexin 
complex 
21
. The CD91 receptor is also expressed on the surfaces of several other cell types 
including macrophages, neurons, and syncytiotrophoblasts 
44
. 
 The JEN-14 epitope has been implicated in the ability of the heme-hemopexin 
complex to recognize and bind to the CD91 receptor since the JEN-14 antibody blocks 
binding of these complexes to the liver cells 
45
. Additionally, it is known that the binding of 
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the HPX protein to this receptor initiates an endocytotic cascade that results in the heme-
HPX being translocated from the blood stream to the interior of the hepatocytes. This 
eventually leads to the capture and recycling of the potentially cytotoxic heme moiety 
45, 46
. 
The JEN-14 epitope spans residues 123-143 (22 amino acids) of the N-domain of rabbit 
hemopexin. A dual sequence alignment using BLAST between the human and rabbit primary 
sequences of the JEN-14 epitope for the two hemopexin proteins is shown below in Table 2. 
 
Table 2.  A two sequence alignment, with statistics, between the primary sequences of 
human hemopexin JEN-14 and rabbit hemopexin JEN-14 respectively. The residues 
highlighted with red are, as explained in the text, positions of missense mutations in the 
human sequence identified in dbSNP. 
 
Score   E-value  Identities  Positives   Gaps      
66.0 bits (148) 1e-14   19/22(86%) 21/22(95%)  0/22(0%)     
Jen-14 
(Human) 
D A A V E C H R G E C Q A E G V L F F Q G D 22 
  |  |  |  |  |  |  |  |  |  |  |  | X  |  | +  |  |  |  |  | +  
Jen-14 
(Rabbit) 
D A A V E C H R G E C Q D E G I L F F Q G N 167 
 
 
Methods 
 
  The Research Collaboratory for Structural Bioinformatics - Protein Data Bank (PDB) 
is a public access repository for crystallographic structure analyses of biological 
macromolecules that has a standardized file format (PDB files) 
7
. Each structure is given a 
unique 4-character alphanumeric designation, the PDB ID.  For the purposes of this analysis 
PDB-ID was used: 
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 1QHU - Mammalian blood serum hemopexin deglycosylated and in complex  
     with its ligand heme 
9
. 
 
 The PDB ID file for 1QHU was downloaded and imported into PyMOL, a computer 
based, 3-dimentional structure visualization program 
35
. The primary sequence of the rabbit 
JEN-14 epitope was superimposed on the entire protein structure at the appropriate location. 
 See Figures 7 - 9 for various graphical representations of the position of the JEN-14 
epitope superimposed on the crystal structure of rabbit hemopexin (1QHU). 
 To check for sequence identity, Position-Specific Iterated (PSI) BLASTs were run on 
the human JEN-14sequence, with an e-value cutoff of e<0.005. Accession numbers for all 
protein used throughout: APPENDIX J. 
 
Results 
 
Figure 7.   Cartoon representation of the position of the JEN-14 epitope (in red) in the 
isolated N-PEX domain of the crystal structure from rabbit (PDB-1QHU). The epitope is 
located in "blade-2" of the domain. 
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Figure 8.   (A) Cartoon representation of the location of the JEN-14 epitope (red) in the N-
PEX domain (oriented to the left) superimposed on the crystal structure of rabbit hemopexin 
(PDB-1QHU); note: bound heme in yellow. (B) Same representation in residue-sphere 
configuration. 
 
 
 
 
Figure 9.   Surface representation of the location of the JEN-14 epitope in the N-domain 
(oriented to the left) superimposed on the crystal structure of rabbit hemopexin  
(PDB-1QHU). 
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Discussion and Conclusions 
 
 The human epitope is 100% conserved in sequence identity in common chimp, 
gorilla, orangutan, gibbon and sooty mangabey (Cercocebus sp.). It shares a minimum of 
95% biochemical positives with virtually all Hominoidea (apes), both Catarrhini (old world 
monkeys) and Platyrrhini (new world monkeys). Additionally, it shares at least 86% 
biochemical identity with all the other primates, down to, and including the lemurs. It shares  
91% positives identity with both Rattus (Norwegian rat) and Mus (mouse), and, furthermore, 
greater than 85% biochemical identity is conserved for the length of the epitope in mammals 
as far removed from humans as cats, Guinea pigs, elephants, naked mole rats, giant pandas 
and flying fox bats. It also shares a respectable 73% biochemical identity with the marsupial 
short-tailed opossum (Monodelphis sp.). Moving "down" the vertebrate phylogeny there is 
still a greater than 70% identity in birds (chicken), and some reptiles (Alligator) Table 3. 
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Table 3.  Comparison of sequence similarity and biochemical identity of the JEN-14 epitope 
of the N-terminal PEX domain from human hemopexin with other selected species 
represented in the NCBI database. 
 
 
 
SPECIES 
Homo sapiens 
 
(%) similarity JEN-14 
primary amino acid 
sequence 
 
 
(%) similarity 
biochemical  
identity  
 
   
Common Chimp 100% 100% 
Gorilla 100% 100% 
Orangutan 100% 100% 
Gibbon 
Mangabey 
Pig 
Cat 
Rat 
Elephant 
Mouse 
Guinea pig 
Naked mole rat 
Flying fox (bat) 
Rabbit 
Giant panda 
100% 
100% 
95% 
91% 
91% 
91% 
91% 
90% 
90% 
86% 
86% 
86% 
100% 
100% 
95% 
95% 
95% 
95% 
95% 
95% 
95% 
95% 
95% 
90% 
Possum 73% 81% 
Chicken 
Alligator 
73% 
71% 
77% 
76% 
 
 
 BLAST searches on the sequence associated with the human hemopexin JEN-14 
epitope hit exclusively on orthologs of hemopexin, regardless of taxon, and importantly, to 
the exclusion of all other proteins that contain 4-blade, β-propeller (PEX) domains. A three 
iteration PSI-BLAST on the human sequence returned 173 hits (at e < 1e-04) all of which 
were specifically identified as "hemopexin". Additionally the first non-hemopexin hit was a 
Warm Water Acclimation Protein (WAP1 - Dicentrarchis labrax: the European Bass). For 
20 
the significance of the evolutionary relationship between hemopexins and WAPs see 
Chapters 3 and 4. 
  This result is even more remarkable because the sequence is only 22 residues in 
length. In this short a sequence it might be assumed that random convergence would lead to 
many more possible matches throughout an exhaustive search of available genomes. 
However, considering this is not the case, it could be argued that not only is this motif 
extremely specific, but might actually be maladaptive in situations where the biochemical 
functionality of the motif could lead to unwanted attraction of the possessor to inappropriate 
binding of an extremely pervasive and promiscuous molecular actor in the CD91 receptor. 
 The remarkable level of evolutionary constraint in this epitope is further 
demonstrated and supported by analyses using the NCBI Single Nucleotide Polymorphism 
database (dbSNP) database to check for known human polymorphisms associated with the 
sequence 
47
. Specifically, the 1000 Genomes initiative database was mined for SNP  
identities 
48
. Within the 22 amino acid sequence of the JEN-14 epitope there are SNPs known 
for 10 positions. However, only 1 has a quantifiable frequency, and that is exceedingly low at 
0.2%. Additionally, the residue change from the expected Valine to the substitute Isoleucine 
is biochemically analogous, both amino acids being hydrophobic/neutral. Furthermore, it is 
interesting that the substitution at position 16 of Isoleucine for Valine is what is seen when 
aligning the human and rabbit sequences; Table 2, residues highlighted in red. 
 These data, taken in concert, support the conclusion that the JEN – 14 epitope is an 
intra-domain (N-terminus) molecular synapomorphy for the family of hemopexin protein 
within vertebrates (i.e. a shared derived character that is assumed to have been inherited from 
a common ancestor). Given that the phylogenetic analyses presented in chapter 3 have 
21 
determined that the hemopexins contain the evolutionarily oldest PEX domains, the JEN-14 
epitope most likely evolved as an original component of these molecules and has remained 
unique to hemopexin. Fascinatingly, there is one 'true' hemopexin (limunectin) found outside 
of the vertebrates in Limulus, the horse shoe crab, an ancient invertebrate. And while Limulus 
does not have iron-protoporphyrin IX associated hemoglobin is does use hemocyanin, a 
copper oxygen binding protein, and human hemopexin has been shown to bind copper 
49
. 
This establishes a plausible link between limunectin and the hemopexins found in 
vertebrates, but it is currently hard to explain or test given the lack of a crystal structure for 
limunectin. 
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CHAPTER 3 
PHYLOGENOMIC ANALYSES PROVIDE INSIGHTS INTO PATTERNS OF 
FUNCTIONAL DIVERSITY BETWEEN PEX-DOMAIN  
CONTAINING PROTEINS 
 
Introduction 
 
 The PEX domain (originally the "hemopexin" domain) is a tertiary protein structural 
motif that is characterized by a sequential arrangement of 4 β-propeller blades surrounding a 
central axis that is the scaffolding site for various metal ions (Figure 1). Aside from the 
hemopexin (proper) molecule there are several other classes of proteins found in Animalia 
that contain PEX domains including the Matrix Metalloproteinases (MMPs), Proteoglycan-4 
(PRG4) and Vitronectin (VTN). There is also a compendium of proteins that have tertiary 
structure identified as the 4-bladed β-propeller (PEX) domain that have been identified in 
Plantae, Fungi and bacterial Prokaryotes. A primary focus of this research is to garner 
insights into the evolutionary relationships of these various PEX domain containing proteins 
to highlight the neofunctional diversification that has arisen evolutionarily despite the 
remarkable architectural constraint exhibited at the tertiary level of structure. What follows is 
a taxonomic survey of PEX-domain containing proteins. 
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I. PEX domains in Animalia: 
 
1. HPX (hemopexin 'proper') 
 
 For a detailed description and discussion of the PEX domains in the hemopexin 
protein (HPX), see Chapter 1. 
 
2. PRG4  
 
 For a detailed description and discussion of the Proteoglycan-4 protein (PRG4), see 
Chapter 5. 
 
3. VTN  
 
 Vitronectin (VTN) is a multifunctional vertebrate plasma glycoprotein that has been 
variously known as: Human S-protein, orepibolin, and Serum Spreading Factor. It is secreted 
into the extra-cellular matrix (ECM) where it recognizes and interacts with an assortment of 
ligands of structurally diverse architecture. The primary structure of the VTN molecule 
contains 459 residues and has a weight of approximately 75 kDa, of which about one third is 
attributed to the carbohydrate moieties 
50
. 
 VTN is a highly modular protein consisting of 3 major domains: a Somatomedin B 
domain (residues 1-39) toward the N-terminus; a domain with sequence similarity to HPX 
(residues 131-342); and a 102 residue region (347-559), also with identity similar to HPX 
24 
toward its C-terminus. This central region of the protein (specifically residues 154-172) is 
predicted to fold as a 4-bladed β-propeller (PEX) domain 51. VTN is also known to exist in 
an alternate two-part form in which cleavage of the apo-protein occurs after the R379 residue 
and held together by the subsequent formation of a disulfide bond 
50
; and is also apparently 
involved in immune system modulation, cell adhesion and migration, blood coagulation and 
fibrinolysis, tissue remodeling, and tumor metastasis 
52
.  
 
4. MMPs 
 
 The Matrix metalloproteinases (MMPs), also known as ‘matrixins’, are a family of 
endopeptidase enzymes primarily responsible for the build-up, degradation, and re-modelling 
of various components of the animal ECM.  
 The MMPs are secreted primarily by cells of connective tissues such as endothelial 
cells, osteoblasts, and fibroblasts; as well as lymphocytes, neutrophils and macrophages, pro-
inflammatory cells of the immune system. The activity and/or structural integrity of these 
proteins are dependent on both calcium and zinc, and they are involved in interactions with 
ECM proteoglycans, other matrix glycoproteins, gelatin, elastins and collagens. They are also 
known to be important in ovarian function, and are regulated variously by cytokines, growth 
factors and hormones 
53
. They have a close functional relationship with a family of inhibitory 
proteins known as the TIMPs (Tissue Inhibitors of Metallo-Proteinases) 
54
. 
 The inclusion of the MMPs in these analyses is a consequence of the majority of them 
having a 4-bladed β-propeller (PEX) domain associated with some aspect of their tertiary 
structure. 
25 
 The MMPs are named by numbers according to the sequence in which they were 
discovered or described. MMPs 4, 5, and 6 were eventually shown to be isoforms of 
previously describe members and hence those numbers are not used. MMPs 7, 23, and 26 do 
not contain PEX domains, and so are excluded from these analyses. For a list of the MMPs 
included in the phylogenies along with a brief description of known functionality, see Table 
A3; Appendix B. Sequence similarity at the PEX-domain level for the human proteins is 
presented in Table A4, Appendix C. 
 
5. WAPs 
 
In the Chordate lineage an orthologous hemopexin gene shows up temporally earliest 
in the cartilaginous fishes: the Little Skate (Leucoraja erinacea), the Nurse Shark 
(Ginglymostoma cirratum) and the White-spotted Bamboo Shark (Chiloscyllium plagiosum) 
55, 56
.  An osteichthyian ortholog has also been identified in the common goldfish (Carassius 
auratus), and was subsequently recognized in several additional bony fish species including, 
but not limited to, the Channel Catfish  (Ictalurus punctatus), the common carp (Cyprinus 
carpio), the Green Swordtail (Xiphophorus helleri), the Japanese Black Porgy 
(Acanthopagrus schlegeli), the Japanese Puffer (Takifugu rubripes), and the Japanese Rice 
fish (Oryzias latipes) 
57-62
.   
The protein coded for by this gene was named "the warm-temperature-acclimation-
associated 65-kDa protein (WAP65)", whereas, when the protein was discovered in the 
chondrichthyes it was called "hemopexin" after its mammalian ortholog. Additional 
investigations also eventually identified a paralog of the first WAP65 in the boney fishes 
26 
resulting in the designation of the separate proteins as WAP65-1 and WAP65-2 respectively. 
Both paralogs are structurally and functionally similar to one another as well as to their 
Chondrichthyan and mammalian hemopexin orthologs 
55
. However, they do exhibit notable 
differentiation in spatially specific expression patterns with WAP65-1 found in multiple 
tissue types, and WAP65-2 being exclusive to the liver 
63
. 
Iron acquisition is known to be a pivotal component of successful bacterial invasion 
and subsequent infection 
64
. Because of the well documented role of hemopexin in capturing 
free heme and its role in sequestering and recycling iron in mammalian systems, coupled 
with the structural similarities of the WAP65 proteins to hemopexin, several studies have 
sought to link similar physiological iron-dynamics functions to the WAP65 proteins of the 
teleosts 
63
. Indeed, both of the paralogous WAP65 proteins have been demonstrated to have 
multiple functionalities involving iron homeostasis, specific immune response, exposure to 
heavy metal toxicity, and development and temperature acclimation 
59, 60, 63, 65-69
. 
Recent work has suggested that the multifunctional nature of the divergent WAP65 
proteins is representative of an entire gene duplication followed by neofunctionalization that 
has left the WAP65-2 protein to perform the original adaptive functions of temperature 
acclimation and immune response (that are similar to what is seen in the extant mammalian 
hemopexin), while the WAP65-1 has evolved variable new functionalities 
55, 63, 70, 71
. Detailed 
structural comparisons, a functional divergence analyses and identification of points of 
positive molecular selection during divergence of the two WAP65 paralogs, along with their 
intra-taxonomic functional distinction from one another, as well as from the mammalian 
ortholog has been achieved 
55
. This study also showed probable strong positive divergent 
selection, significantly influencing the evolution of these three proteins since the time of the 
27 
duplication of the WAP65 paralogs in the teleosts. This study was also able to document 
marked increased acceleration of positive selection on the mammalian hemopexin, as 
compared to either of the WAP65's. Additionally, it makes a compelling case that the 
discernable selection differences in the three proteins were independent of the ability of any 
of them to bind heme. 
 
6. PEX domain in invertebrates 
 
 In the horseshoe crab (Limulus polyphemus), a 54-kDa protein isolated from 
amoebocytes and named "limunectin" has been discovered and described 
72
.  Assays have 
established that it binds to a phosphocholine and pneumococcal C-polysaccharide in a 
calcium independent manner, and also participates in several cascades involving activities in 
the extra-cellular matrix 
72
. The binding kinetics are relevant to distinguish limunectin from 
another immune system protein known as “C-reactive protein” (named for its affinity for the 
“C”-carbohydrate antigen of Pneumococcus), which has been shown to only bind in the 
presence of free calcium 
72, 73
. At the time it was discovered, the researchers establish 
"limited sequence homologies" to segments of collagenase (now MMP1), gelatinase (now 
MMP2), and vitronectin (VTN). It is now obvious that the "limited" aspect of the similarity 
is, in fact, the PEX domains of those respective proteins. 
 Limunectin is found mainly in the secretory granules of Limulus amoebocytes and 
was predicted to function as an adhesion molecule capable of recognition and neutralization 
of invasive pathogenic microbes. In its role as an adhesin recognition protein it is thought to 
play a crucial part in the immune response in Limulus 
72, 73
. 
28 
 Immunoglobulins are absent and, as such, obviously, the only immunity Limulus 
exhibit is innate. It has been hypothesized, however, that coordination between complement-
like proteins, agglutinins and lectins, potentially work in functional synergisms to afford 
horseshoe crabs with, while not a classically defined adaptive immunity, potentially a 
"souped-up" version of innate immunity 
72, 73
. The evolutionary longevity of genus Limulus 
certainly speaks to the efficacy of such a putative adaptation. 
 A structure for limunectin has not been reported, so presented here are two homology 
models from the primary sequence that show remarkable similarity in tertiary structure to 
mammalian hemopexin, Figures 10 and 11.   
 
 
 
Figure10.   Homology model of Limunectin from TASSER-I protocol. Lateral view. Note 
obvious similarity in overall tertiary structure to chordate hemopexin
74-76
. 
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         (a)       (b) 
 
Figure 11.   Homology model of Limunectin from TASSER-I protocol threaded onto 
(1QHU). a) face-on view of the N-domain; b) face-on view of the C-domain. Again, note 
obvious similarity in overall tertiary structure of the β-propeller domains to chordate 
hemopexin. 
 
 
The class Xiphosura is thought to have arisen in the Paleozoic Era (570–248 MYBP), 
and representative fossils have been dated to a minimum of 445 MYBP, therefore this 
lineage has an extremely deep evolutionary foundation 
77, 78
. The presence of limunectin in 
this arthropod poses several fascinating challenges from an evolutionary standpoint. For 
instance, due to the ancient nature of any divergence patterns from shared common ancestors 
with Limulus, if limunectin is a homolog of hemopexin, then the ancestor of the hemopexin 
protein would itself have to have shared this deep evolutionary origin, and pre-date the 
appearance of phylum Chordata. This seems a very unlikely scenario. However, the 
alternative is, in many ways, just as improbable, namely that limunectin and hemopexin are 
examples of evolutionary convergence at the level of the entire protein. 
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II. PEX domain in Plantae 
 
 A PEX domain has been identified in a seed albumin protein (PA2) of the garden pea 
plant (Pisum sativum). It has been proposed that the protein structure is comprised, most 
likely, of a 2 β-barrel globular construction that resembles the classic 4-bladed propeller 
described for the PEX domain 
79
. The presence of this tertiary structure in plants would 
suggest that the evolution of the PEX domain architecture predates the divergence of plants 
and animals at the kingdom level. Since the discovery of the PA2 PEX domain, several more 
have now been seen, not only in multiple species, but in several different plant proteins. It 
has been suggested that one prime metabolic function of these HPX domain-containing 
proteins in legumes involves polyamine metabolism and, potentially, protection from heme-
induced oxidative stress; and in rice they may be involved in the degradation of chlorophyll 
26, 28, 29
.  
 
III. PEX domain in Fungi 
 
 The kingdom level divergence is further evidenced by the discovery, in fungi, 
specifically the oyster mushroom (Pleurotus ostreatus), of a 4-bladed β-propeller domain that 
is structurally and functionally similar to the PA2 albumins isolated from various leguminous 
seeds and rice (Oryza sativa)
29
. This protein has been named "ostreopexin" 
31
. (However, see 
discussion, Chapter 5, for more detailed speculations on the evolutionary origin of this 
domain in Pleurotus). 
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IV. PEX domain in Prokaryotes 
 
1.  Domain Bacteria 
 
 A 4-bladed β-propeller (PEX domain) has been discovered in a bacterium, 
Photorhabdus luminescens. This bacterium is a member of the symbiotic gut flora of 
nematodes that infect insects, and secretes virulence factors known as “high molecular mass 
toxin complexes”. These toxin complexes are thought to be released by the nematodes into 
the hemolymph of an infected insect host, and to act to subvert the insect’s immune response 
and to set up a suitable environment for reproduction of both the bacterium and the 
nematode. This protein was named photopexin. During analyses of these virulence factors 
two open reading frames (ORFs) were discovered which, when expressed, translate into two 
isoforms of photopexin, ppxA (564 amino acids) and ppxB (340 residues), both with serial 
repeats and sequence similarity to the PEX domains of interest. The potential roles in 
pathogenicity of the two photopexins are still not known. However, many pathogenic gram-
negative bacteria are known to utilize iron as a metabolic resource, and to possess outer 
membrane heme-binding and heme-transporting proteins 
30
. Therefore, it is possible that, in 
this case, the bacteria are co-opting a eukaryotic-like heme “scavenging” molecule to hi-jack 
the host insect’s iron for their own metabolic and biochemical needs. Also, importantly, it is 
known that Caenorhabditis elegans, and some parasitic helminths are incapable of 
synthesizing heme on their own, even though they have physiological needs associated with 
several biochemical pathways involving hemoproteins. It is therefore necessary for these 
worms to exogenously acquire the heme needed for their biological processes 
80
. It is 
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furthermore reasonable to assume that any capability these helminths might co-opt from 
other organisms that aids in iron acquisition would be of tremendous adaptive significance. 
More on the potential evolutionary implication of this speculation is presented in Chapter 5. 
 
2. Domain Archaea 
 
 After an exhaustive search of various formulations of PEX domain-specific 
descriptive primary sequences, these analyses have determined that, to date, there is no 
reported evidence of a 4-bladed β-propeller structural domain existing in any proteins 
described within Domain Archaea. 
 
Methods 
 
Phylogenies 
 
 To assess the evolutionary relationships between the various PEX domain containing 
proteins phylogenetic analyses were performed at several levels. First, a phylogeny of the 
mature protein groups from humans (HPX, MMPs, PRG4 and VTN), together with the 
WAPs and HPXs from fishes, and Limunectin from the horseshoe crab was deduced. The 
Maximum Likelihood consensus is presented in Figure 12. Secondly, the phylogeny for just 
the isolated PEX domains from the human groups, plus the fish WAPs, and Chondrichthyan 
HPXs was inferred and shown in Figure 13. Finally, a phylogeny of representative PEX 
domains across Kingdoms from Animalia, Plantae, Fungi, and Bacteria is displayed in 
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Figure 14. Statistical details for all phylogenetic analyses are indicated in the text for each 
figure. All phylogenetic analyses were conducted using the Molecular Evolutionary Genetics 
Analysis, Version 7.0 suite of software (MEGA7) 
81
. 
 
Results 
 
 The evolutionary history of the 8 groups of mature PEX domain containing proteins 
from humans and fishes, rooted with Limunectin, was inferred by using the Maximum 
Likelihood method based on the Jones, Taylor and Thornton (JTT) matrix-based model 
82
. 
The bootstrap consensus tree inferred from 500 replicates is taken to represent the 
evolutionary history of the taxa analyzed 
83
. Branches corresponding to partitions reproduced 
in less than 50% of bootstrap replicates are collapsed. The percentage of replicate trees in 
which the associated taxa clustered together in the bootstrap test (500 replicates) are shown 
next to the branches 
83
. Initial tree(s) for the heuristic search were obtained automatically by 
applying Neighbor-Joining and BioNJ algorithms to a matrix of pairwise distances estimated 
using a JTT model, and selecting the topology with superior log likelihood value. The 
analysis involved 28 amino acid sequences. All positions containing gaps and missing data 
were eliminated. There were a total of 240 positions in the final dataset. Evolutionary 
analyses were conducted in MEGA7 
81
 (Figure 12). 
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Figure 12.   Molecular Phylogenetic analysis of ENTIRE PROTEINS with PEX DOMAINS 
(Homo + WAPs + Limunectin) by Maximum Likelihood method. Numbers represent 
bootstrap values from 500 iterations. 
 
 The evolutionary history of the isolated PEX domains from the same suite of proteins 
as in Figure 12 was inferred by using the Maximum Likelihood method based on the JTT 
matrix-based model 
82
. The bootstrap consensus tree inferred from 500 replicates is taken to 
represent the evolutionary history of the taxa analyzed 
83
. The percentage of trees in which 
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the associated taxa clustered together is shown next to the branches. Initial tree(s) for the 
heuristic search were obtained automatically by applying Neighbor-Joining and BioNJ 
algorithms to a matrix of pairwise distances estimated using a JTT model, and selecting the 
topology with superior log likelihood value. The tree is drawn to scale, with branch lengths 
measured in the number of substitutions per site. The analysis involved 22 amino acid 
sequences. All positions containing gaps and missing data were eliminated. There were a 
total of 133 positions in the final dataset. Evolutionary analyses were conducted in  
MEGA7 
81
 (Figure 13).  
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Figure 13.   Molecular Phylogenetic analysis of PEX DOMAINS (Homo + WAPs) by 
Maximum Likelihood method. 
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 The evolutionary history of isolated PEX domains across kingdoms was inferred by 
using the Maximum Likelihood method based on the JTT matrix-based model 
82
. The 
bootstrap consensus tree inferred from 500 replicates is taken to represent the evolutionary 
history of the taxa analyzed 
83
. Branches corresponding to partitions reproduced in less than 
50% bootstrap replicates are collapsed. Initial tree(s) for the heuristic search were obtained 
automatically by applying Neighbor-Joining and BioNJ algorithms to a matrix of pairwise 
distances estimated using a JTT model, and selecting the topology with superior log 
likelihood value. The analysis involved 54 amino acid sequences. Evolutionary analyses 
were conducted in MEGA7 
81
 (Figure 14). 
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Figure 14.   Molecular Phylogenetic analysis by Maximum Likelihood method of isolated 
PEX domains across kingdoms. 
 
 
For detailed discussion of results see Chapter 4. 
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CHAPTER 4 
DISCUSSION AND CONCLUSIONS - EVOLUTION OF THE 4-BLADED  
β-PROPELLER (PEX) DOMAIN 
 
Discussion  
Implications for human health 
 
 One basic premise of these analyses is that understanding the evolutionary 
foundations of the structural constraints on the PEX domain, and the associated biochemical 
and cellular functionalities, has direct relevance to issues related to human health. 
Camptodactyly-Arthropathy-Coxa vara-Pericarditis (CACP) syndrome is a rare autosomal 
recessive condition that leads to progressive severe deterioration of any bone-to-bone contact 
that is a result of progressive damage due to the lack of the lubrication normally provided by 
PRG4 (Lubricin) 
84, 85
. As the name suggests, this is a condition that is manifested quite 
variably at the clinical level, but strong linkages indicate that, regardless of the presentation 
of pathologies, there is genetic homogeneity as the underlying causative factor. In a recent 
European cohort study of 13 patients who suffer from CACP, 5 novel mutations in their 
PRG4 genes were characterized. Two of these are nonsense mutations in the PEX domain 
coding region of the PRG4 gene. Both of these mutations lead to truncated translation of the 
N-terminal region of the protein and have been shown to disrupt tissue binding 
86
.  
 Malfunction in the normal physiological activity of the MMPs have been shown to be 
associated with a wide-ranging pantheon of human diseases including arthritic suites, 
osteoporosis, cirrhosis of the liver, and aortic aneurisms, as well as other chronic and acute 
40 
cardiovascular conditions 
87
.  Another consistent pattern has implicated individual or 
combinations of MMPs in a variety of cancers, and more specifically in the processes of 
angiogenesis, tissue reorganization and metastases. Consequently, the MMPs, as a class of 
proteins, have long been considered prime targets for pursuing molecular level treatments for 
malignant cancer pathologies 
87-94
. Many of these studies have explicitly highlighted 
dysfunction of the normal cellular processes associated with the PEX domains of these 
proteins as possible mechanistic drivers of the various pathologies. Regrettably, it has been 
determined through multiple attempts at discovering or producing effective inhibitors for 
malfunctioning MMP-related pathologies that the extreme functional-plasticity of the 
hemopexin domains makes accurate modeling of domain specific inhibitors quite 
problematic 
95
. 
 Unfortunately, a series of papers suggesting different functions for hemopexin have 
been published 
96-99
. These studies have been thoroughly refuted 
49
. However, the incorrect 
functions have occasionally made their way into annotation of HPX or HPX-like proteins. 
This is especially true in cases where automated updating has been used, and persists even in 
Gene Ontology annotations This has seriously complicated the evolutionary and phylogenetic 
studies of HPX and related proteins, and has led to incorrect phylogenetic interpretations, 
especially where weighting for function has been employed. 
 Recent work has also shown higher expression in the eyes of diabetics: hemopexin is 
overexpressed in the retinal pigment epithelium (RPE) of diabetic patients with diabetic 
macular edema (DME) and induces the breakdown of RPE cells which can manifest as 
diabetes induced loss of vision, leading even to total blindness 
100
. There has also been 
additional evidence that the role of hemopexin in sequestering and recycling free heme is a 
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prime factor in the control of oxidative stress and ancillary inflammatory maladies. This 
research indicates that it is worthwhile to consider the pursuit and development of 
hemopexin-specific therapy protocols that could derive a new level of protection from the 
adverse effects of oxidative stress-mediated inflammatory conditions caused by 
overproduction of free heme. Among the more significant human health disorders in this 
category is atherosclerosis 
101
. 
 
Evolution of the PEX domain 
 
 A divergent evolutionary origin of the PEX domain containing proteins was first 
proposed in 1987. Early generation gene alignment analyses concluded that nucleotide 
sequences in the gene that coded for what was at the time known as the "Spreading protein" 
('S-protein' now termed: Vitronectin) matched sequences previously described for hemopexin 
and transin (MMP3) 
102, 103
. A "pexin gene/protein" family was proposed as a collective term 
in recognition of the likelihood of the discovery of additional proteins that would contain 
recognizable 4-bladed β-propeller (PEX domain) tertiary structure. 
 There is evidence that in early stages of vertebrate evolution, with the emergence of 
the fish, blood chemistry pathways arose in response to the necessity of dealing with the 
removal of deteriorating, senescent and dysfunctional erythrocytes, and the concomitant 
release into the plasma of hemoglobin protein and its prosthetic heme moieties.  Phylogenetic 
analyses have established that the gene that codes for the protein haptoglobin arose 
subsequent to the divergence between the urochordata (tunicates) and Osteichthyes (bony 
fishes). Haptoglobin, a transport protein with very high affinity to bind free hemoglobin, 
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probably evolved from a protease antecedent (MASP, mannose-binding lectin-associated 
serine proteinase), a complement-associated protein involved in the innate immune system of 
the ancestral lineage. Interestingly, haptoglobin subsequently disappears from the genomes of 
some Lissamphibia (specifically anurans) and Aves. This evolutionary loss may be a 
consequence of haptoglobin being potentially maladaptive under certain conditions. 
Nevertheless, there then arose a structurally (and assumed evolutionarily) nonrelated analog 
to haptoglobin, used for hemoglobin capture and removal in the birds and is known as PIT54 
(a.k.a. 18-B) 
104, 105
. This hypothesis is further supported by evidence that multimeric 
haptoglobin evolved independently twice within the mammals, suggesting that these alternate 
forms might mitigate the uncharacterized "disadvantages" of the original protein 
105
. 
 Parallel to the evolution of haptoglobin, several other proteins that target the removal 
of free heme and other potentially cytotoxic radicals from the plasma appear in the early 
phylogenic record. Among these ancillary proteins are a1-microglobulin (a.k.a. - Protein HC) 
and hemopexin. The hypothesis that haptoglobin evolved from an ancestral protease 
associated with the innate immune system is very intriguing, and a hypothesis of a similar 
and/or parallel evolutionary origin for hemopexin should be explored 
105
. Further hypotheses 
might suggest, given the high association of the majority of the PEX domain containing 
proteins, most specifically hemopexin, with the animal immune system, that this suite of 
blood plasma proteins may have played an integral role in the original emergence and 
evolution of adaptive immunity in the Vertebrata. 
 The Warm Water Acclimation Proteins (WAPs - see Chapter 3) in bony fishes have 
been known for some time, but the evolutionary emergence of the hemopexin protein in 
vertebrates has been traced back to the cartilaginous fishes 
56
. An ortholog has not been 
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identified, to date, in the genomes of jawless vertebrates or any other "lower deuterostomes" 
and so it is assumed to have arisen during the second documented round of vertebrate 
genome-wide duplication and to have appeared, coincidentally, with tetrameric hemoglobin 
106
. However, the known presence of Limunectin in a protostome (horseshoe crab - 
Xiphosura) makes this interpretation somewhat problematic, in that parsimony would suggest 
and origin for hemopexin that predates any protostome/deuterostome cladogenisis
72
. 
 Earlier studies had deduced that the hemopexin protein was a complex of sequences 
that had evolved from ancestral molecular precursors, and as such, is the most derived of the 
proteins containing the PEX domain 
107
. However, the phylogenetic analyses of primary 
amino acid sequences in this work has determined that hemopexin is, most likely, the 
evolutionarily ancestral molecule, at least when compared to the domains of the various 
mammalian MMPs (see Figure 10). If it can be established that the protein Limunectin, a 
potentially major component of the innate immune system in horseshoe crab (Limulus 
polyphemus) is an ortholog of hemopexin, and is not convergent, then this interpretation 
(hemopexin-proper as ancestral) would be bolstered by the very deep divergence 
(450+MYBP) of the extant lineages in which it is found. 
 
Interpretations of phylogenies 
 
 The phylogeny of the mature proteins in Homo (with WAPs, and Limunectin for 
comparisons) follow the patterns already uncovered in previous investigations, and render no 
new insights 
63
. In general the clades are predictable, although meaningful evolutionary 
explanations remain to be determined, especially regarding the MMPs (Figure 12). It is 
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notable, that rooting the clade with Limunectin (as indicated) supports the contention that the 
two-domain WAP/HPX proteins are ancestral rather than derived, even though the single 
domain proteins (PRG4, VTN and MMPs) are structurally "simpler" (due to having only one 
PEX domain). The clade is rooted with Limunectin purely on the phylogenetically historical 
fact of a deep protostome/deuterostome divergence. 
 Concerning the phylogeny calculated for the isolated PEX-domains of the individual 
proteins, the N and C domains of the HPX/WAP proteins are tight and unequivocal (Figure 
13). According to this analysis, the WAPs, Chondrichthyan hemopexins and Mammalian 
hemopexins are homologous, not just at the protein level but also at the level of the two 
separate individual PEX domains (both N and C terminal positions). Therefore, not 
surprisingly, the "hemopexins" are homologs. However, it is fascinating that the N- and C- 
halves of the dual domain proteins are NOT sister clades (Figure 13). This is relevant given 
the remarkable similarity in 3D structure (RMSD - 1.009 Å) generated by peptides that share 
only 47% sequence identity (Figure 6). This result suggests a need to rethink the traditional 
use of primary amino acid sequences as characters in phylogenies where the evolutionary 
questions are exclusive to structural relationships and those relationships may obscured 
because of how the search algorithms currently work. These observations certainly warrant 
further investigation.  
 According to this phylogeny, it is also apparent that Proteoglycan-4 (PRG4) and 
Vitronectin (VTN) are phylogenetically sister proteins, and interestingly clade together, and 
away from the PEX domains in other proteins. But, from there, all manner of interpretation 
possible for the rest of this phylogeny, produced from the primary sequences of the isolated 
PEX-domains from the same proteins presented in Figure 12, is confusing at best. There is 
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no consistency in the arrangements of the clades within the MMPs. And, more importantly, 
there is no supportable statistical congruence between the mature proteins phylogeny and that 
of their respective individual isolated PEX-domains.  
 The incongruence of these phylogenies suggests an evolutionary trajectory for the 
PEX domain independent of that of the "parent" proteins. This is interpreted as phylogenetic 
evidence of the supposition of evolutionary exaptation at the level of the 4-bladed  
β-propeller (PEX) domain, discussed later 108, 109. 
 There are several notable observations concerning the patterns seen in the best 
calculated inter-kingdom phylogeny (Figure 14). First, and foremost, is that the clades 
intersperse within the phylogeny and do NOT fall into a predictable separatory branching 
pattern based on a priori expectation of straight inter-kingdom divergence.  
 On the other hand, taking isolated groupings into consideration, one definitive 
outcome is that the Photosystem II proteins of the grasses (Viridiplantae: monocots) form a 
very tightly supported clade, and have a much higher number of substitutions than any other 
statistically significant grouping (Figure 14). This is biologically consistent, in that it is 
known that the monocots are the most derived of the extant Viridiplantae 
110
. One avenue of 
future research will be to delve into this pattern deeper to see if it might be possible to better 
parse the pivotal role of these proteins, and their modifications of photosynthetic efficacy, 
during the adaptive evolution of the monocots. One aspect of the physics at the molecular 
level that raises some excitingly fascinating evolutionary possibilities is that heme and 
chlorophyll are both derived from a common precursor protoporphyrin IX differing in that 
heme contains iron and chlorophyll contains magnesium. 
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Potential Horizontal Gene Transfer of the PEX domain 
 
 Aside from the apparent lack of predictable divergence patterns, the most striking 
observation that emerges from the inter-kingdom phylogenetic analysis is the tight 
relationship indicated between Ostreopexin (Kingdom Fungi) and Photopexin (Kingdom 
Bacteria) (Figure 14). This may be evidence of a multi-tiered example of inter-kingdom 
Horizontal Gene Transfer (HGT) or "adaptive genetic capture". HGT (a.k.a. Lateral Gene 
Transfer) is a well-known phenomenon, but is usually associated with bacterial genomes, the 
mechanisms of which (transformation, transduction or conjugation) are all very well studied 
and accepted. 
 Historically, however, HGT in eukaryotic organisms has been thought to be, from 
early on "impossible" to more recently "improbable" to currently "proven" 
111
. Considerable 
amounts of evolutionary investigation have now established that, not only is HGT possible in 
eukaryotic genomes, it is common enough to have now been observed in all three domains of 
life 
112
. 
 One ecological context in which HGT appears to be particularly common, not only 
between eukaryotic genomes, but potentially between eukaryotes and prokaryotes (and vice 
versa) is in host-parasite interactions, both in Animalia and Plantae 
113, 114
. Pertinently, there 
have recently been several analyses that have suggested HGT from host organisms has 
occurred in parasitic nematodes 
115, 116
. Therefore, there is a reasonable likelihood that the 
PEX domain (photopexin) seen in the Photorhabdus protein is a eukaryotic sequence that has 
been acquired, though HGT, from either a host that the nematode parasitizes, or some other 
intermediate associate, and is now used to the adaptive advantage of both the bacterium and 
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its associated nematode symbiont. If the original function of the domain in the hosts (or 
intermediate) was to capture, sequester, or remove potentially cytotoxic heme and/or iron, 
then the bacterium now has the capability of essentially turning an infected insect's immune 
defense against it as a virulence factor. If the mechanism of virulence then is the capacity to 
rob the host of iron that can subsequently be used for the metabolism and survival of the 
bacteria, this in turn would aide in the nematode's ability to thrive.  
 Of course, there is always the possibility that this structure and associated potential 
functionality has arisen through strict convergence, but the absence of the discovery, to date, 
of a broad occurrence of the PEX-domain in prokaryotes argues against that possibility. 
However, if convergence is the case, it could be interpreted in a pseudo-ecological context as 
an equally interesting example of a protein evolving as a molecular "mimic" of the host's 
original "model" domain. 
 The work with ostreopexin suggests that it may participate in intracellular 
management of metal (II or III)-chelates 
31
. The primary function of the fungal protein 
'ostreopexin' is not known, but similar to the proteins in Plantae, it shows reversible binding 
to hemin with moderate affinity 
31
. However, it does not bind to polyamines.  
 BLAST searches (Positon Specific Iterative (PSI) - BLAST with Max Score cut off of 
minimum = 200) run on the ostreopexin protein with a Kingdom 'Fungi' specific filter shows 
the possibility of some sequence homology with three other fungi, Rhizoctonia solani (a 
known plant pathogen), Hebeloma cylindrosporum (an ectomycorrhizal basidiomycete), and 
Auricularia subglabra (a jelly fungus related to the edible Auricularia polytricha, common 
name: cloud ear). However, at this point, all three proteins are hypothetical, based 
exclusively on genome builds from each of those organisms. Additionally, each, while 
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meeting the Max Score minimums, was in the low range (204-223). The phylogenetic 
relationships, if any, of these fungi to Pleurotus will be investigated further. 
 
Conclusions 
 
 When the analyses in this work were initially undertaken, reports in the databases 
suggested that the hemopexin protein was composed of two PEX domains connected by a 
flexible linker (which is correct), but that the primary sequence consisted of only 5 pexin 
sequence repeats. Therefore, earlier structural investigations were premised on the erroneous 
indication that each PEX domain was composed of two sequence repeats (HPX repeats) 
corresponding to blades 1 and 2 of each of the 4-bladed β-propeller domains and the fifth (or, 
actually, 3
rd
) sequence repeat was the heme-binding linker. This work, however, has 
discovered that each domain does, in fact, contain 4 primary sequence HPX repeats that 
match each of the four blades of the individual domains (see Chapter 1). Therefore, the 
hemopexin protein contains, in reality, 8 sequence repeats. Repeats 1-4 associated with the 
N-domain, 5- 8 with the C-domain. Contrary to earlier analyses that described the linker 
region between the two domains, where the heme moiety is bound, as a "hemopexin repeat", 
it, in fact, is not.  
 
Exaptation and modular neofunctionalization 
 
 In 1979 Steven J. Gould and Richard Lewontin proposed a revolutionary new way of 
attempting to understand phenotypic traits that might have been, and are being, acted upon by 
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natural selection 
108, 117
. They argued that instead of routinely and habitually utilizing the 
prevailing "adaptationists" interpretations to tell "just-so-stories" about why particular traits 
are seen in nature, and that, evolutionary biologists needed to begin to actively and 
aggressively work toward developing more rigorous analytical techniques to investigate the 
true origins and trajectories of extant phenotypes. This, of course, pre-dated (and perhaps 
presaged) the emergence of much more sophisticated molecular techniques, and so was 
meant to address mostly the analyses of gross phenotypic realities, principally at the 
individual organismic level. The primary novelty of the paper was to propose that particular 
traits that appear, on the surface, to have arisen solely by natural selection as a function of 
simply "being adaptive" may be misleading; in other words they argued against the standard 
interpretation of the time that, the mere FACT that it is seen, indicates it MUST, by 
definition, be "adaptive" or it wouldn't be here. A major accomplishment of this publication 
was to usher in a profound, reflective conversation proposing a re-evaluation of the 
significance and importance of the concepts of evolutionary constraint (biochemical, 
biophysical, developmental) and Genetic Drift, as being driving mechanisms that could lead 
to the extant presentation of phenotypic traits. 
 Additionally, the Spandrels paper identified two other constructs that are particularly 
relevant to the results presented in this work. First, that classic selection, and adaptation, may 
have been at work, but in multiple, concurrent, temporal and spatial streams that eventually 
lead to differential phenotypes. Ultimately, in this sense, the issue becomes, that, even though 
the trait (in this case the PEX domain architecture) is certainly adaptive, and was probably 
selected for, the ability to distinguish the variable adaptive significance of the differing forms 
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is obscured; in this instance, the "differing forms" present as the biochemical plasticity of the 
domain. This is manifested theoretically as the "problem of multiple adaptive peaks" 
108
. 
 The second hypothesis arising from the Spandrels paper that is directly relevant to 
these current findings is the idea of the "spandrel" itself. In their paper Gould and Lewontin 
coopt an architectural term for use as an analogy to the evolutionary principle they describe. 
In architecture, a spandrel is a roughly triangular space that is the result of the lateral 
placement of two or more supportive arches. Historically these "found spaces" were then 
used by artisans as areas in which to place decorative sculpture or other types of art. The 
point that Gould and Lewontin make is that the spandrel is a by-product of the architecturally 
"adaptive" functionality of the arch, but is then available to be utilized for purposes other 
than what was originally "selected for".  
 In the case of phenotypic traits, the nature of the evolutionary spandrel is that the 
character may have initially been under positive selection because it is (was) adaptive, in its 
original sense, but subsequent secondary functionality arises from the already existent trait. 
The secondary function may itself be adaptive, however, the important distinction is that it 
(the secondary function) was NOT the reason that the trait evolved in the first place. This 
particular aspect was further codified and expanded upon in a follow-up paper by Gould and 
Vrba in which they coined more apt biological terminology and labeled these evolutionary 
spandrels: "exaptations" 
109
. This general line of reasoning actually predates the publication 
of the "Spandrels" paper in a very prescient offering by Franҫois Jacob entitled Evolution 
and Tinkering 
118
. 
 While the phylogenetic analyses presented in this study show relatively consistent 
and predictable trajectories of evolutionary association within kingdoms, the between 
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Kingdom analysis that attempts to uncover the deeper evolutionary history of the PEX 
domain shows a complete lack of consistent patterns of divergence history (Figure 14). 
Attempts at building a phylogeny with these data using differing modeling protocols (e.g. - 
Maximum Parsimony) actually resulted in muddling the relationships even worse (data not 
shown). 
 The presence of the PEX domain, specifically in Pleurotus, raises an extremely 
interesting possibility, especially in juxtaposition with Photopexin in Photorhabdus. It has 
been well documented for some time now that Pleurotus is a carnivorous fungus. Not only 
that, but their major prey is nematodes. Oyster mushrooms eat nematodes 
119
. Again, the 
phylogenetic analysis suggests a close sequence identity (potentially interpreted as a close 
evolutionary relationship) between the PEX-domains of Ostreopexin and the bacterial 
Photopexin which is found in the gut flora of a host nematode. While no definitive evidence 
exists in these analyses, the speculation arises that there may be a parasitic/symbiotic 
mechanistic explanation for the apparent close evolutionary relationship of these particular 
two PEX-domain containing proteins. Additionally, some very recently published research 
sheds some extremely pertinent light on the ability of the pathogenic Pleurotus to rapidly 
adapt to changing host mediated environmental selective pressures
120
. If the use of the PEX-
domain would be of any adaptive advantage, especially as relates to iron acquisition, to this 
facultative plant parasite, then it is not improbable that the Ostreopexin PEX-domain has 
been exapted from either a host plant organism, or from its predator-prey relationship to a 
nematode that had previously exapted it from elsewhere. Again, the lack of an established 
pattern of divergent heredity within the taxon (Fungi) might be interpreted as evidence for a 
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HGT event manifested in the genome of the virulently plant-parasitic oyster mushroom (that 
also happens to prey upon nematodes). 
 Recent work on the possibility of exaptation at the protein domain level has resulted 
in some very intriguing modeling showing that there is a fine balance between two critical 
biophysical traits: binding affinity for target ligands and tertiary folding stability. This 
research resulted in the hypothesis that at the protein domain level there exist fitness 
landscapes that give rise to evolutionary coupling between binding strength and folding 
stability 
121
. Using a mathematical model they showed how biophysical protein traits 
(structure) can develop as exaptations (spandrels) even though they do not impart an 
"intrinsic fitness advantage" 
121
.  
 These discoveries have much more to do than with just esoteric discussions of 
evolutionary theory. They have real world empirical applications when investigating the role 
that protein structure may play in, for example, applied medical research: 
 
  …such proteins may have divergent fates, evolving  
  to bind or not bind their targets depending on random  
  mutational events. These observations may explain the  
  abundance of apparently nonfunctional interactions among  
  proteins observed in high-throughput assays. 
121
 
 
 The results of these analyses combine to lead to the conclusion that the other proteins 
that have identifiable PEX domain structure have co-opted the 4-bladed β-propeller which 
has then been modified for variable functionality. This research has verified that the β-
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propeller structure has not been maintained via consistent amino acid sequences through 
time. Instead, the propeller structure has remained relatively unchanged even as the 
component residues of the propellers have been labile over long periods of evolutionary 
history. 
 Despite the difficulty in tracing obvious homology, it is most likely that the surviving 
PEX domains found throughout extant biota share a common evolutionary origin. It is 
extremely unlikely that the similarities seen at the structural level are a mere coincidental 
aspect of convergent (or even parallel) evolutionary processes. However, one very concrete 
conclusion drawn, based on these analyses, is that there has been so much evolutionary time 
for the primary sequences to have diverged so significantly from one another at the 
nucleotide and concomitant residue levels, as to be almost "unclade-able".  
 Because the domain simply does not conform to traditional taxonomic patterning, one 
conclusion might be that the "adaptive capacity" of the domain lies in its structure, and 
attendant functional plasticity. Consequentially, it is the associated biophysical and 
biochemical properties that unite the domains at the biological level, not their primary 
sequences.  
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CHAPTER 5 
DETERMINATION OF THE TERTIARY STRUCTURE OF THE PEX 
DOMAIN IN THE HUMAN PROTEOGLYCAN-4 (LUBRICIN) PROTEIN  
 
Introduction 
 
 Proteoglycan-4 (PRG4) is the name given to the protein encoded by the PRG4 gene in 
mammals. In the literature this protein has been variously named: superficial zone protein 
(SZP), megakaryocyte stimulating factor (MSF), and lubricin 
85
. Currently, it is most 
commonly known as "lubricin", a descriptive name that refers to its primary biological 
function, which is to act as a lubricant in the synovial joints of vertebrates 
122
.  
 PRG4 is a glycoprotein, of 151 kDa approximate size, synthesized by articular 
chondrocytes and certain cells associated with the tissues of the synovial linings of the 
articular joints 
123
. Dysfunction in this protein is rare, but those that exhibit clinical symptoms 
suffer from a disease state known as Camptodactyly-Arthropathy-Coxa vara-Pericarditis 
(CACP) syndrome, an autosomal recessive trait (OMIM 208250) 
124
.  Patients who inherit 
any of the mutations that compromise lubricin functionality are born with normal joint 
activity, but as they age they begin to exhibit a progression of symptoms that starts with 
hyperplasia of the synoviocytes of the joints 
125
. This in turn leads to progressive 
malformation of the digits of the hands and feet (camptodactyly) and eventually, severe 
arthropathies that result in premature contracture of their joints. In many, they progress with 
age to severe hip deformity (coxa vera), and pericarditis 
126, 127
. 
 Protein domains are defined as specific portions of proteins that are evolutionarily 
conserved in primary sequence and tertiary structure 
128
. They are also assumed to be able to 
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exist independently from the parent protein in which they are typically found, and have the 
ability to obtain their own stable 3-dimensional structure 
128
. Many specific domains are 
found in multiple proteins and can be described as molecular "building blocks" that evolution 
has available for rearrangement into new and potentially adaptive protein function. The 
primary structure of the human A-isoform of the PRG4 protein contains a polypeptide of 
1,404, residues. It is not atypical that proteins of this size are composed of several potentially 
functional modular components, or domains 
128
. However, even though the structure of 
PRG4 has yet to be determined, it seems that this particular protein may contain only one 
identifiable modular domain: the 4-bladed β-propeller PEX domain 2, 129-131 (also see: 
Chapter 1). The remainder of the protein, as best we can determine through homology 
modeling, is unstructured (Figures 23 and 24). 
 PRG4 is one of a variety of classes of proteins that contain the PEX domain. This 
domain is known to also occur in most of the Matrix Metalloproteinases (MMPs) and 
vitronectin (VTN), and the blood glycoprotein Hemopexin (HPX), for which the domain is 
named 
132-134
. In this section of this study we propose to express and purify the Human PRG4 
(proteoglycan-4) PEX domain, obtain the tertiary structure of the domain using nuclear 
magnetic resonance (NMR) spectroscopy and/or crystallization, and perform phylogenomic 
structural sequence analyses to aid in placing the PRG4-PEX domain in its proper 
evolutionary context in relation to the other PEX domain containing proteins.   
 The principal significance of understanding the evolution, and hence functionality, of 
this domain is that mutations in the genes that code for, and malfunctions in their 
subsequently translated protein products, are known to be implicated in the development 
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and/or exacerbation of a multitude of human diseases including CACP syndrome, rheumatoid 
arthritis, several types of cancers, cirrhosis of the liver, and multiple sclerosis, among  
others 
87
. We hypothesize this work will help to identify structural components of these 
proteins at the modular/molecular level that could be potential targets for drug therapy design 
aimed at mechanistic intervention of the PEX domain function. 
 Often, the determination of the three-dimensional structure of any given protein 
domain is extremely valuable (sometimes even crucial) information necessary for 
understanding the biological functions of the protein molecules in which they are found. 
Additionally, and most importantly for the purposes of this study, protein domains can 
evolve. Recently, the analytical approach known as phylogenomics has been developed to 
provide a framework for evolutionary analyses that can be performed using the previously 
established 3-dimentional structural aspects of protein domains as character states in cladistic 
analyses 
135
. One fundamental issue is that the structure of the PEX domain of PRG4 has not 
been determined. While certainly not the only PEX domain that lacks resolved structure, we 
believe the PRG4 protein PEX domain may provide a critical link in understanding the 
evolutionary implications of the variation in tertiary structure of this domain between the 
various protein classes in which it is found. 
 Previous bioinformatic work has shown that the PRG4 protein contains a single C-
terminal PEX structural domain, and most significantly, earlier phylogenetic analyses of 
genes known to code for proteins containing PEX domains have suggested that the PEX 
domain seen in PGR4 is the evolutionarily ancestral sequence 
107, 136
. Therefore, at least in 
Animalia, the PRG4-PEX domain has been interpreted to be the root of the phylogeny at the 
domain level. Paradoxically, previous work has suggested that hemopexin is the most derived 
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of the proteins within the group, while establishing PRG4 as the evolutionary progenitor of 
the domain
107
. This phylogenomic work, however, sheds some doubt on that interpretation 
and places the 2 PEX domains of the HPX molecule at the root of the phylogeny, signifying 
it as the ancestral condition (Chapter 3). A major impetus for deeper understanding of PEX 
domain evolution will be to build a parallel phylogeny of the proteins that are expressed by 
these genes to evaluate congruencies and discrepancies between the two hypotheses.  
 While the 3-D structure is known for the mature hemopexin protein, and several of 
the MMPs, the structure of the PRG4 PEX domain remains elusive. We propose to use X-ray 
crystallography and nuclear magnetic resonance (NMR) techniques to establish the 3-
dimensional structure of the PGR4 PEX domain. This, in turn, will facilitate building a more 
robust evolutionary phylogeny of the domain structure, and have the PGR4 representative to 
bolster the phylogenetic hypotheses. 
 From a more theoretical perspective, these analyses should shed light with deep 
implications on the evolution of the highly specialized and adaptive capacity of the 
exclusively vertebrate acquired (a.k.a.- adaptive) immune system 
137
. Whereas, the MMPs are 
known to function as components of the ancestral innate immune system, the hemopexin 
protein (proper) belongs to the acute phase class of immune reactants in some animals 
(although not in humans) and is secreted through induction after an immune system 
inflammation response, exclusive to the derived adaptive system dynamics 
138, 139
. Therefore, 
it is possible that identifying the origin of the PEX domain will provide a better 
understanding of the evolution of adaptive immunity and hence a clue to therapeutic 
approaches targeting immune dysfunction at the molecular level. 
58 
 Even though PRG4 is a very heavily O-glycosylated protein, evidence suggests that 
very little, if any, glycosylation occurs in the C-terminus PEX domain region 
140
. As a 
consequence, this portion of the protein should be amenable to expression in a prokaryotic 
system. X-ray crystallography and Nuclear Magnetic Resonance (NMR) are the two 
techniques most often employed to obtain data that can then be used to calculate the relative 
positions of atoms, in space, within molecules that can be used in the determination of 
protein tertiary structure.  X-ray diffraction is used on single crystals of purified protein 
product, and is highly effective at aiding in the determination of 3-D structure in 
comparatively large mature proteins. In contrast, NMR is frequently more effective at 
illuminating detail of atomic-resolution for smaller constituent domains or structural motifs 
of larger mature proteins, and at detecting inter-domain movement and conformational shifts 
141, 142
.  
 Solution-NMR is a technique in which indirect information can be obtained that can 
be used to calculate the three-dimensional structure of proteins. Measurements are made 
directly on the protein sequence in a near physiological chemical environment 
141
.  For the 
purposes of this work, we are interested in determining the structure of the single PEX 
domain of lubricin (PRG4).  
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Methods and Results 
 
Cloning, expression and purification 
 
 The prime target of this experiment is the recombinant production of the PEX domain 
from the PGR4 protein. The nucleotide sequence for cloning into an expression vector was 
obtained from Integrated DNA Technologies (IDT), in the form of their commercial product 
known as a gBlock® 
143
. The model we used to build the synthetic PRG4-PEX domain gene 
was obtained directly from the primary sequence reported in the NCBI database from Human 
PRG4 Isoform B (NCBI Reference Sequence: |NP_001121180.2). 
 gBlocks are synthetic, double-stranded, oligonucleotide gene fragments, the 
sequences of which are dictated specifically by the investigator and are optimized for codon 
usage by particular expression systems. In this case, we optimized the sequence for 
expression in E. coli, based on the translational primary structure of the human PRG4-PEX 
domain. As a consequence, even though actual nucleotide sequences differ somewhat 
between the human "model" and the synthetic gBlock codons, the primary structure of the 
peptide is identical. Ultimately, the primary aim was to insure a synthetic sequence that 
would "mimic" the code for the PRG4- PEX domain region of the human PRG4 gene, but be 
adjusted for more efficient translation in E.coli. The nucleotide sequence for the gBlock used 
in this work, as ordered, and the primary structure of the polypeptide as expressed are shown 
in Appendix E. 
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Cloning - Introduction 
 
 An optimized series of laboratory protocols for cloning and expression of proteins in 
E. coli was employed to attempt to isolate, purify, stabilize and prepare the peptide sequence 
for attempts at crystallization and spectroscopic analyses 
144
.  We determined that we would 
attempt to clone the PRG4 PEX domain (gBlock) into the pET-44a vector obtained through 
EMD-Millipore 
145
. We decided to insert the gene into the vector between the EcoRI and 
XhoI restriction sites. A schematic of the pET-44a vector map is provided in Appendix F.   
 In addition to providing ampicillin resistance in the soon to be transformed E. coli, 
the pET-44a vector is fused with a 495 amino acid protein from E.coli called "N-utilization 
substance protein A" (NusA). This protein is known to function in a variety of cellular and 
viral transcription termination and antitermination processes 
146
. However, the prime reason 
for using this construct is that NusA is known to have among the highest solubility of all 
bacterial proteins 
147
. Having attempted an expression protocol using a different cloning 
vector/cell strain combination (vector plasmid pHisGb1 and DH5a competent cells) but not 
achieving success in purification due the product being highly insoluble (results not shown), 
we reasoned that by using this vector we might "drag" the target peptide (the PRG4-PEX 
domain) into solution via the high solubility properties of the Nus-Tag. In addition to the 
NusA-Tag, this construct has a poly-histidine tag (His-Tag) used for purification by 
immobilized metal ion affinity chromatography (IMAC) 
145
.  Between the NusA sequence 
and the PEX domain is a protease recognition sequence for enterokinase (rEK).  After digest 
with enterokinase (rEK) the resulting protein will have a nine amino acid (SPGARGSGF)  
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N-terminal tail before the first residue of the PEX domain as a leftover artifact from the 
fusion protein. 
 
PCR gBlock (PEX domain) amplification for cloning 
 
 Polymerase Chain Reaction (PCR) is a well-established methodology for 
amplification of nucleotide (gene) sequences via in vitro enzymatically assisted (DNA 
polymerase) replication 
148
. The sequence optimized gBlock (synthetic gene) for the PRG4 
PEX domain and appropriately calculated primers for PCR amplification and cloning were 
all obtained in lyophilized form from IDT, and suspended in ultra-pure deionized water as 
per the manufacturer's instructions to achieve 100 µM concentrations of each. Actual 
volumes and additions are described after sequences below. The sequence of the gene 
(gBlock) is provided in Appendix E. The primers used for PCR amplification were: 
 
Forward primer: 
 
Sequence name: PRG4_EcoRI PEX-forward:  
Oligo Sequence: 5'- GCT ACA GTC GAA TTC CCG AAC CAG GGC ATT -3' 
Calculated Molecular Weight: 9,176.0; Measured Molecular Weight: 9,175.4 
Amount received: 34.6 µmoles + 346 µl = [100 µM] of forward primer.  
 
The "cut" sites for both restriction enzymes are shown in RED: 
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Reverse primer: 
Sequence Name: PRG4_XhoI_PEX2-reverse: 
Oligo Sequence: 5'- ACG GTC TCG CTC GAG CTA TGG GCA ATT GTA CCA -3' 
Calculated Molecular Weight: 10129.6; Measured Molecular Weight: 10129.60 
Amount received: 29.4 µmoles + 294 µl = [100 µM] of reverse primer. 
 Reactants for the PCR amplification were all mixed into a standard 0.2 mL low 
retention PCR tube, Table 4 149. 
 
Table 4. Reactants and volumes used in the PCR amplification of the PRG4-PEX domain 
gene (gBlock). 
 
REACTANTS VOLUME 
10X polymerase buffer 5µl 
DMSO 3µl 
dNTP (deoxyribonucleoside triphosphates) 1µl 
5' forward primer 1µl 
3' reverse primer 1µl 
Template DNA (PEX-gene) 1µl 
PFu DNA polymerase 1µl 
Ultra-pure deionized water 37µl 
TOTAL           50µl 
 
 
 PCR reactions were run on a Perkin Elmer GeneAmp 2400 PCR system 
150
, using the 
automated program shown in Table 5. The DNA polymerase we chose is an enzyme that has 
been isolated from hyper-thermophilic archaeon Pyrococcus furiosus (abbreviated Pfu). In 
vivo this polymerase not only drives replication of the organism's genome, but it also 
functions as a proofreader, recognizing and repairing any mis-incorporated nucleotides in the 
63 
3' direction of extension. This multiple functionality along with innate superior 
thermostability ostensibly results in PCR products with fewer errors than those generated by 
other available retail polymerase products (e.g. Taq) 
151
. DMSO was added to assist in 
keeping the strands of the DNA separated and increasing replication efficiency, especially in 
G-C rich regions 
152
.  
 
Table 5. PCR program for amplification of PRG4 PEX domain gene (gBlock). 
 
TEMPERATURE DURATION NOTES 
95
o
 C. 5 minutes Hot Start 
   
95
o
 C. 2 minutes  
52
o
 C. 1 minute 
>>>Sequence repeat 
30x 
72
o
 C. 1.5 minutes  
   
4
o
 C. Over night Cool down and storage 
 
 
Preparation of agarose gel for isolation of PEX domain oligonucleotide (PRG4 PEX gene) 
 
 A 1% agarose gel solution was prepared by adding 1g agarose (Midsci: BE-A500, 
Bullseye agarose, General Purpose 
153
) to 100mL of standard TAE (TAE is Tris-Acetate-
EDTA) buffer; heating in a microwave oven for 1 minute to dissolve the agarose; cooled to 
approximately 50
o
 C (just warm to touch). To the cooled but still liquefied gel prep 2µl of 
GelRed Nucleic Acid Stain was added for eventual visualization of oligonucleotides 
154
. The 
gel was poured into the electrophoresis tray and allowed to sit at room temperature for 20-30 
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mins, until completely solidified. The gel was placed into the electrophoresis chamber, the 
unit filled with 1xTAE until the gel was submerged. Two µl of loading buffer/blue dye (5x 
SDS loading dye = 250mM Tris pH 6.8, 30% glycerol, 10% SDS, 5% β-mercaptoethanol, 
0.02% bromophenol blue) was mixed with 8 µl of PCR product (total 10 µl) for well loading 
accuracy and increasing sample viscosity. A ThermoFisher Scientific 1Kb GeneRuler 
molecular weight ladder/standard was loaded (2 µl dye + 2 µl ladder + 8µl H2O = 12 µl total 
volume) into lane 1 of the gel for size calibration 
155
. Replicate samples of the PCR product 
were loaded into lanes 2 and 3, and run for 30 minutes at 110V to observe the presence of an 
appropriately sized nucleotide band representative of the target  (PEX domain gene - 828 bp: 
Appendix E). Results are presented in Figure 15.  
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Figure 15.  Agarose gel resolving the PEX-domain PCR product, for check on the 
efficacy of amplification. 
 
 The target "gene" is 828 base pairs (bp) in length. Lane 1 is the DNA size 
ladder/standard. The top band in each of the two sample lanes (lanes 2 and 3) falls between 
the 750bp and 1000bp marker, and was interpreted as being the target product.  The smaller 
bands further down the gel were not analyzed and are presumed to be by-products of the PCR 
reaction that arose from secondary priming sites. The lowest "cloud" is most likely primer. 
Several PCR experiments were performed. The example gel was typical of the pattern 
consistently observed when amplifying the PEX domain, but represents the clearest result. 
 Separate gels, for isolation of the plasmid vector (pET-44a) DNA were run following 
the same protocol (data not shown). 
 
PEX domain 
PCR product 
828 bp 
750 bp 
1000 bp 
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PCR clean up - DNA purification by centrifugation 
 
 The gene DNA product was purified using the Wizard SV Gel and PCR Clean-up 
System – A9281 from Promega 156.  Selecting a visually high quality electrophoresis the best 
band associated with the PCR product was excised and placed it in a pre-weighed 1.5 ml 
microcentrifuge tube. The tube plus gel extract was weighed to determine the amount of gel 
present. The gel slice for the gene fragment weighed 740mg. 740µl of Membrane Binding 
Solution was added, and the tube was vortexed (agitated) for 20 seconds and set in a 42
o
 C 
water bath until gel was completely melted. The solution was briefly vortexed for complete 
mixing and transferred to an SV Minicolumn inserted into a collection tube and was allowed 
to incubate at room temperature for 1 minute, then centrifuged at 14800 rpm for 1min. Flow 
through was discarded and 700µl of Membrane Wash Solution (mixed with ethanol) was 
added to the SV Minicolumn which was centrifuged, again, at 14800 rpm for 1 min. The 
flow through was discarded. 500µl of Membrane Wash Solution was added to the column 
and centrifuged at 14800 rpm for 1 min. The flow through was discarded and the empty 
minicolumn centrifuged again at 14800 rpm for 5 min. The minimal flow through was 
removed and the tube was re-centrifuged at 14800 rpm for 1 min to facilitate evaporation of 
residual ethanol. The minicolumn was transferred to a clean 1.5mL microcentrifuge tube. 50 
µl of nuclease free (ultra-pure) water was applied to the center of the minicolumn filter, and 
allowed to equilibrate at room temperature for 1 minute. The tube was centrifuged at 14800 
rpm for 1 minute to collect the DNA eluate. The SV Minicolumn was discarded and the 
DNA eluate (~50µl) stored at 4
o
 C. 
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Plasmid digest and gel purification 
 
 Both insert (PEX domain gene) and the vector (pET-44a plasmid) were digested in 
separate tubes in preparation for ligation according to the recipes in Table 6. 
 
 Table 6. Recipes for Insert (PEX domain gene) and Vector (pET-44a) digestion  
 in preparation for DNA Ligation insertion of gene into vector plasmid. 
 
RXN Digest  VECTOR Digest 
Insert (PEX gene) 50µl  Vector (pET-44a) 50µl 
NEBuffer 2* 6 µl  NEBuffer 2* 6 µl 
Enzyme - EcoRI 2 µl  Enzyme - EcoRI 2 µl 
Enzyme - XhoI 2 µl  Enzyme - XhoI 2 µl 
TOTAL VOLUME 60 µl  TOTAL VOLUME 60 µl 
 
 * The NEBuffer 2 was chosen because it is rated as 100% efficient with both EcoRI 
and XhoI enzymes. The biochemical properties of digestion buffer "NEBuffer 2" are 
indicated in Table 7. 
 
Table 7. Biochemical properties of digestion buffer "NEBuffer 2" 
157
. 
 
1X Buffer Components 
50mM NaCl 
10mM Tris-HCl 
10mM MgCl2 
1mM DTT 
pH 7.9@25°C 
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 Each digestion tube was spun for 1 minute to mix the solution and incubated in a 37
o
 
C water bath overnight. 
  
Purification of digested insert and vector DNA 
 
 Both the insert and vector digests were run on a 1% agarose gel, the bands identified, 
verified for size, excised and gel purified as described above, with the exception that the 
vector band gel weighed 820 mg and the insert band gel weighed 670 mg. Additions of 
reagents were adjusted accordingly. 
 
DNA ligation  
 
 The T4 DNA Ligation Protocol of Promega corporation was followed 
158
. It was 
determined that the PGR4-PEX gene would be inserted into the pET-44a vector plasmid 
between the EcoRI and XhoI restriction sites; see Appendix F, for pET-44a vector map and 
location of restriction enzyme cut sites.  
Concentrations of both vector and insert solutions were determined through Optical Density 
at A260 using an Eppendorf BioPhotometer 6131 Spectrophotometer 
159
. The concentration of 
DNA insert (PEX domain gene) was determined as 22.5 ng/µl and that of the vector (pET-
44a) as 15.6 ng/µl. Due to the need to account for the difference in size of the two sequences 
(PEX domain = 828 bp; pET-44a = 7711 bp) conversions were calculated to derive the 
appropriate volumetric additions of each for both a 3:1 and 9:1 molar ratio ligation mixtures. 
69 
The resulting ligation reaction mixtures are indicated in Table 8. A Vector Control of 3.2 µl 
Vector DNA (pET-44a) with 6.8 µl Ultra-pure water (total volume 10 µl) was included. 
 
     Table 8. Recipes for ligation reactions at 3:1 and 9:1 molar concentration ratios of insert 
     (PEX domain gene) to vector (pET-44a), note conversion factors in text above. 
 
Ligation RXN 3:1  Ligation RXN 9:1 
Insert DNA (PEX gene) 
(16.7 ng) 
0.74 µl 
 Insert DNA (PEX gene) 
(50 ng) 
2.22 µl 
Vector DNA (pET-44a) 
(50 ng) 
3.2 µl 
 Vector DNA (pET-44a) 
(50 ng) 
3.2 µl 
T4 Ligase buffer 10 µl  T4 Ligase buffer 10 µl 
T4 Ligase 1 µl  T4 Ligase 1 µl 
Ultra-pure water 5.06 µl  Ultra-pure water 3.58 µl 
TOTAL VOLUME 20 µl  TOTAL VOLUME 20 µl 
 
 The reactions were incubated at 16
o
 C overnight. 
 
Transformation 
 
 After ligation was complete three, 20 µl cells/aliquots of DH5a competent E.coli cells 
were removed from the -80
o
 C freezer and allowed to thaw on ice
160
.  Two µl of the 3 
ligation reactions (3:1 molar ratio; 9:1 molar ratio; and control) were added to the separate 
tubes of cells and incubated on ice for 30 minutes. The cells were heat shocked by partially 
submerging the tubes in a 42
o
 C water bath for 40 seconds. The cells were allowed to recover 
for 5 minutes on ice. The cells were transferred to new microcentrifuge tubes containing 100 
µl of Lysogeny Broth (LB - Luria formulation: 10 g tryptone + 5 g yeast extract + 5 g NaCl 
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suspended in 800 ml deionized water + additional DI H2O to constitute 1 L volume; 
autoclaved at 121 °C for 20 mins). Preparations were incubated with 250 rpm agitation at 37
o
 
C for 1 hour. Tubes were removed from the incubator and spun at 16.1 xg for 2 minutes at 
room temperature. Each sample was added separately onto LB plus ampicillin (0.1 µg/ml 
concentration) agar plates using disposable sterile plastic cell spreaders (one for each) and 
incubated a 37
o
 C overnight to allow colony growth. Viability of cells was assured by success 
of colony growth evaluation experiments described below. 
 
Colony growth evaluation 
 
 Plates were removed from the incubator and visually assessed for bacterial colony 
formation. There were 3 colonies on the vector control indicating that most of those bacteria 
did not acquire ampicillin resistance.  This was expected because, even though the bacteria 
most likely took up the treatment, since the vector was empty (un-ligated) the transformation 
did not impart ampicillin resistance. There was growth present in both the 3:1 (8 colonies) 
and 9:1 (29 colonies) molar ratio treatments.  
 
Colony PCR 
 
 Colony PCR methodology is a convenient method for rapidly testing whether a 
plasmid transformation was successful on a per colony basis. This protocol is a high-
throughput approach to rapidly test for plasmid uptake without having to run a time 
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consuming, and potentially unsuccessful, plasmid extraction miniprep on each colony 
separately. All twelve colonies used were from the 9:1 molar ratio treatment plate.  
 
DNA plasmid extraction from E. coli colonies 
 
 For the PCR experiment the protocol described above for the PCR gBlock (PEX 
domain) amplification for cloning was used, except that each PCR reaction tube was 
inoculated separately with an individual bacterial colony prior to the addition of the PCR 
master mix, and excluding the PRG4 PEX domain gene addition. The PCR products were 
analyzed for the presence or absence of the plasmid by standard 1% agarose gel 
electrophoresis, also described above.  
 Twelve culture tubes (one for each selected colony) were prepared by adding 4 ml of 
liquid LB mixed with 4µl ampicillin (0.1 mg/ml concentration) to each. The colonies were 
visually selected for the colony PCR experiment and sampled with sterile pipet tips, which 
were used to inoculate both the PCR tubes and the broth in the growth tubes. The results of 
the gel analysis of the colony PCR amplification experiment using the 12 colonies selected is 
shown in Figure 16. 
 
 
 
 
 
 
72 
 
 
 
 
Figure 16.  Colony PCR of transformed ligation products of the PRG4 PEX domain-pET-
44a construct.  Colonies were taken from the 9:1 molar ratio treatment plate. Colonies 4, 7 
and 11 (equivocal) appeared not to contain the PEX domain insert. This gel was run without 
a standard or an "empty" plasmid run, by design, based on information gained from prior 
experiments concerning expected protein composition and size category of the expression of 
the PRG4 - PEX domain (see Figure 15 above). 
 
 Based on colony PCR results, samples 1, 5, 8, and 9 were selected for culture growth 
overnight in a 37
o
 C shaker at 200 rpm. From each culture 1.5 ml was collected into sterile 
microcentrifuge tubes for further processing by plasmid DNA extraction using the IBI High-
Speed Plasmid Mini Kit protocol 
161
. 
 Tubes were centrifuged at 14800 rpm for 1 min. to pellet the E.coli cells, and the 
supernatant was discarded. To each tube was added 200 µl of PD1 buffer containing  
PRG4-PEX 
domain PCR 
product 
1 2 3 4 5 6 7 8 9 10 11 12 
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RNase-A (see protocol for components and properties of buffers used 
161
). Cells were 
resuspended by vortexing. 200 µl of PD2 buffer was added to each tube and gently mixed by 
10 times tube inversion. After 2 minutes at room temperature 300 µl of PD3 buffer was 
added, 10 times inversion mixed and centrifuged for 3 minutes at 14800 rpm. Each 
supernatant was pipetted off and placed into PD columns set in 2 ml collection tubes and 
centrifuged at 14800 rpm for 1 minute. Flow throughs were discarded and columns were 
loaded with 400 µl of W1 buffer. After centrifugation at 14800 rpm for 30 seconds the flow 
through was discarded. 600 µl of Wash Buffer (with ethanol added) was placed on each PD 
column and centrifuged at 14800 rpm for 30 seconds. The flow through was removed and the 
empty PD column/tubes re-centrifuged at 14800 rpm for 3 minutes to dry the PD column 
matrix. The dried PD column was transferred to a new sterile microcentrifuge tube and 50 µl 
of Elution Buffer was pipetted onto the center of the PD column matrix. After 3 minutes at 
room temperature to allow for matrix saturation, columns were centrifuged at 14800 rpm for 
2 minutes to elute the plasmid DNA into the collection tube. The yield was approximately 50 
µl of eluted DNA from each sample. 
 
Recombinant sequence verification 
 
 Samples of purified plasmids were sent to the University of Missouri DNA 
Sequencing Core Facility for analysis 
162
. Colony 8 was found to contain no errors (see 
Appendix G) and was subsequently used for expression tests.  
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Protein expression and purification 
 
 Additional plasmid was purified by miniprep from colony 8 for transformation into E. 
coli strain BL21-DE3 competent cells, for protein expression, following the heat-shock 
protocol outlined above. Initial attempts at protein expression using standard strength LB 
medium failed, as insufficient quantity of protein was produced for continued analyses. 
However, higher yields of the NusA-PEX fusion polypeptide were obtained using double 
concentrated LB medium as a growth environment.  
 1 L of 2xLB media was inoculated with a 1:20 overnight culture of transformed 
bacteria and incubated for 2-3 hours at 37
o
 C, with shaking. Protein expression was induced 
by addition of 1 mM final concentration of isopropyl β-D-1-thiogalactopyranoside (IPTG), 
the incubation temperature was lowered to 18
o
 C, and incubation continued for 12-16 hours. 
Cells were collected by centrifugation at 1000 xg for 15 minutes at 4
o
 C in a Beckman JA -10 
rotor. The supernatant was discarded and the cell pellet was frozen at -20
o
 C.   
The cell pellet was thawed on ice, re-suspended in 100 mL Lysis buffer (20mM Tris 
pH 8.0, 500 mM NaCl, 5% glycerol, 5 mM imidazole) with 10 μM leupeptin. Cells were 
lysed by passing 3x through a micro-fluidizer via gravity load 
163
.  The lysate was centrifuged 
at 10 Kxg for 1 hour.  The supernatant was passed over a 2.5 cm column packed with 2.5 ml 
Ni Sepharose 6 Fast Flow medium, equilibrated with 25 ml of Lysis buffer 
164
.  The column 
was washed with 25 ml of Lysis buffer containing 100 mM imidazole to remove non-specific 
binding proteins. The NusA-PEX domain protein was eluted by 25 ml of Lysis buffer with 
250 mM imidazole (a total of approximately 4-5 mg of protein eluted in the initial 2-3 ml). 
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As this step was simply a test to determine if using the 2x LB medium was effective 
at producing more protein than with 1x LB, only one round of gel de-staining was performed. 
This was sufficient for visualization of target protein as seen in Figure 17. 
 
Figure 17.   Change in media to double LB - Soluble NusA-PEX fusion protein is now 
present in the supernatant and the 2nd elution fraction (E2) is considerably cleaner than E1. 
a = pre-induction; b = crude lysate; c = supernatant; d = pellet; FT = flow through; 
R = rinse; E = elusions (progressive). The same size standard is run in both lanes 1 and 10 
165
. 
 
The molecular weight of the NusA tag is ~54 kDa and the PRG4-PEX domain is 
~31.51 kDa 
166
 . Therefore, the topmost bands that present in the two elution lanes (E1, E2) 
on the gel above are interpreted to be the NusA-PEX fusion target. 
 
Protein production/elution maximization 
 
Several rounds of expression and elution experiments were run to determine the best 
conditions for maximization of protein quantity and reduction of non-target background 
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proteins. One set of tests was designed to establish the most procedurally productive 
concentration of imidazole for comparatively highest quality of protein elution (Figure 18). 
 
Figure 18 – One example of results from experiments run under the same background 
conditions as the gel shown in Figure 17, but manipulating concentrations of imidazole 
required to produce the cleanest fraction of NusA-PEX domain fusion. Each lane was loaded 
with 10µl of materials. PC = Pre-column; FT = Flow Through; F = Fractions 
 
 Figure 18 is a representative gel of the expression tests run to determine if changing 
the concentration of imidazole would affect the quality of protein expression. These 
experiments were only looking at the relative purity of the expression band for direct 
comparison of imidazole concentration efficacy. Consistently, the 25mM imidazole 
concentration produced the cleanest expression patterns and so was initially chosen for future 
expressions (however, see modifications to procedure associated with subsequent salt 
addition experiments below. 
 A second round of experiments was designed and conducted to determine if the 
addition of various divalent metals to the expression medium would positively affect target 
77 
protein production. The logic behind these experiments was that the PEX domain, in all cases 
known, is a scaffold for the binding of a variety of potentially catalytically active metal ions 
(Zn, Ca, Na, among others 
167
). It was reasoned that addition of these ions might potentially 
result not only in increased quantity of target expression, but would also possibly aid in post-
expression folding of the domain. The series of metal salt additions included CaCl2, FeSO4, 
CuSO4 and MgCl2. There was no appreciable improvement in target protein production 
regardless of additive, and therefore, no data are presented from those experiments. From this 
point, based on the results of this suite of expression tests, a 25mM imidazole concentration 
preparation was chosen to move forward for use in isolation and purification protocols. 
 
Digestion of target NusA-PEX domain fusion protein 
 
The selected protein fraction (25mM imidazole preparation) was buffer exchanged 
back to Lysis buffer (10ml G50 column equilibrated with 10x column volume Lysis buffer) 
to remove the excess imidazole. The sample was diluted to ~0.5 mg/ml and concentrated to 
1-2 mg/mL 
168
.  Concentration was measured by Bradford protein assay at 595 nm 
absorbance 
169
. The fusion protein was digested with 1 unit of recombinant His-tagged 
enterokinase in 50 µl of 1x rEK cleavage/capture buffer for 24 hours at room temperature, 
Table 9 
170
.  
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Table 9. Recipe for digestion reactions involving the NusA-PEX fusion protein. 
 
REACTANTS VOLUME 
10X rEK Cleavage/Capture Buffer 5 µl 
NusA-PEX fusion protein (50 µg) 25 µl 
Diluted rEK (1 unit/µl) 1 µl 
Deionized water 19 µl 
Total volume 50 µl 
 
 100 µl of Ni sepharose beads equilibrated with 1 ml Lysis buffer were added to the 
solution (30 minutes with gentle shaking) to bind the uncut fusion protein, digested NusA 
protein and enterokinase. Ni sepharose beads were separated from the solution by packing in 
an empty 1 ml (1 cm diameter) column and washing with 200 µl Lysis buffer.   
 
Separation of NusA tag from PEX domain 
 
 During the 24 hour digestion cycle, a time-course series of samples were taken at 2, 4, 
8 and 19 hours. For each sample 10 µl of digestion solution was removed and the digestion 
reaction halted by addition of 2 µl of loading dye and heating in a micro-tube heating block 
for 5 minutes at 95
o
 C. After the reaction was quenched the samples were maintained at room 
temperature until loading onto the gel. Results are presented in Figure 19.  
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Figure 19.  Time-course digest of the 25mM Imidazole fraction with Recombinant 
Enterokinase (rEK).  
 
 The NusA-PEX fusion degrades at a relatively steady rate with the concomitant 
(albeit weaker) appearance and increase in the amount of both free NusA and free PEX. By 
19 hours the NusA-PEX fusion is completely digested. Additionally, all other contaminants 
appear unaffected by the rEK suggesting they are not truncation variants of the fusion. 
However, the persistence of these contaminants is indicative of considerable non-target 
product being expressed. 
 Considering that the digest shows there is some PEX domain being expressed, but 
there are still high levels of non-target protein contamination, the previous experiment was 
repeated and the gel was de-stained multiple rounds to minimize background. The gel was 
submitted for Mass Spectroscopy analysis in the Mass Spec lab of UMKC-SBS run by Dr. 
Andrew Keightley. The analysis confirmed that boxes A and C are the NusA-PEX fusion 
protein; box B is the PEX domain and box D is GroEL, Figure 20. 
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Mass Spectrometry  
 
 
 
Figure 20.   Gel submitted for Mass Spectroscopy analysis. Lane 1: molecular weight 
ladder/marker.  Lane 2: undigested elution from the first round of the Ni column purification 
procedure.  Lanes 3-6 are elution fractions, post digest (treated with rEK) from the 2nd round 
of Ni column purification.  Lane 7 is an alternate low range molecular weight ladder used 
simply as a secondary reference 
171
.  
 
 Comparing lane 2 to 3 on this gel, there is a noticeable lightening of band C, as 
compared to band A, and the simultaneous appearance of band B, supporting the conclusion 
that the NusA-PEX fusion is digested by the rEK. The boxes outlined on the figure were 
positively identified by the Mass Spec analysis as: boxes A and C confirmed to have NusA-
PEX fusion protein; box B confirmed to be the PEX domain; and box D is GroEL. 
 All Mass Spectroscopy analyses were performed in the University of Missouri 
Kansas City - School of Biological Sciences Proteomics and Mass Spectrometry core Facility 
81 
directed by Dr. Andrew Keightley 
172
. MS analyses proceeded in two steps. The first step was 
in-gel trypsin digestion, and the second step was nanoLC-High Resolution Mass 
Spectrometry (LC-MS). 
 
In-gel trypsin digestion 
 
 Coomassie stained gel bands were first excised and dehydrated with 100µL 
acetonitrile. Protein disulfides were reduced by swelling the dehydrated gel with 50µL 50 
mM ammonium bicarbonate buffer containing 100 mM DTT (30 minutes). A second 
dehydration with acetonitrile was performed and subsequently alkylation by re-swelling with 
50uL buffer containing 100mM chloroacetamide (30 minutes). The gel with reduced and 
alkylated protein was dehydrated with acetonitrile and re-swollen with 50mM ammonium 
bicarbonate buffer (to affect buffer exchange, and dilution/removal of alkylating reagents), 
dehydrated again with acetonitrile and swollen in a second buffer (50mM H4HCO3 at pH7.8 
+ 20 µg/mL porcine modified Trypsin), and allowed to digest at 37
o
 C overnight 
173
.  
 Peptides were extracted twice with 15µL 70% acetonitrile: 30% water. Extracted 
peptides were dried down to ~2µL, and diluted in 20µL 0.1% Formic acid (aqueous) for 
further analysis. 
 
NanoLC-High Resolution Mass Spectrometry (LC-MS) 
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 The extracted peptides were analyzed by capillary nanoflow LC-tandem MS using a 
50µm I.D. X 12cm long capillary column packed with Phenomenex Jupiter C18 reversed 
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phase matrix. Peptides were resolved with a linear gradient of acetonitrile (2-40% acetonitrile 
over 90 minutes) at a flow rate of 250 nL/min (Eksigent binary LC system) and loaded in 2% 
acetonitrile, 0.1% Formic acid (aqueous phase). For MS data acquisition, a Q Exactive Plus 
mass spectrometer, was operated in data-dependent mode in which one mass spectrum (MS, 
70,000 resolution) and fifteen dependent HCD spectra (MS2, 35,000 resolution) were 
acquired per cycle throughout the acquisition 
175
.  
 Protein identifications were made using Mascot protein identification software, 
searching against SwissProt_2017_01 (553,474 protein sequences) with decoy database 
included (reversed database) 
176, 177
. Mass tolerances for the searches were 10 ppm precursor, 
and 0.01 Dalton fragment mass. Search results were filtered using 95% confidence (chances 
of no more than 1 in 20 that the match is random), and with a threshold of expected value 
equal to or below 0.05 imposed. Additional technical specifications of individual MS 
identifications are presented in APPENDIX H. 
 
Ancillary experiments 
 
 With the presence of GroEL confirmed, the apparent relatively low yield of 
unassociated PEX-domain (as evidenced by the weakness of banding at Box 2 - Figure 20) 
could be explained by its association with the bacterial chaperonin protein 
178
. While this 
situation certainly presents a difficulty in attempts at purification of the PEX domain, it does 
also provide evidence that the domain must be folding to a certain extent to remain bound to 
the chaperonin. 
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 A high-salt addition purification experiment was run on the NusA-PEX domain 
fusion protein in an attempt to dislodge the PEX domain from the purported chaperonin 
(GroEL). All conditions and volumetrics are the same as presented for the previous 
experiments and outlined on page 73, with the exception that cells were re-suspended after 
pelleting in Lysis buffer containing 1.5 M NaCl instead of the 0.5 M NaCl used previously.  
1.5 M NaCl was maintained in all buffers during subsequent purification attempts Figure 21. 
 
 
 
Figure 21.  High-salt purification of NusA-PEX domain fusion protein. The addition of 1.5 
M NaCl instead of the previously utilized 0.5 M NaCl proved to be more effective than any 
other experimental manipulation at increasing target protein yield. IMD = Imidazole. 
 
 
 Contrary to earlier protein expression test which determined that 25 mM imidazole 
would be best, after the addition of the high salt component the 250 mM imidazole 
concentration treatment produced considerably cleaner elution fractions. The 50 mM 
84 
imidazole did show good fusion protein production but the 250 mM concentration was 
chosen over it due to relative purity. 
 
Fast Protein Liquid Chromatography (FPLC) 
 
 In an attempt to purify the minimal amount of post-digest PEX domain protein, the 
250 mM imidazole fraction was buffer exchanged back to < 25 mM imidazole and digested 
with rEK, under the same conditions as outlined above, and an additional purification step 
using gel filtration via AKTA Fast Protein Liquid Chromatography (FPLC; Bouyain Lab) 
was performed 
179
. 500  µl of protein solution was loaded onto a Superdex 200 10/300 GL 
prepacked column and eluted in HBS (HEPES buffered saline: 20 mM HEPES/150 mM 
NaCl), Figure 22 
180, 181
.  
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     Figure 22. Results of FPLC analysis on the 250 mM imidazole fraction from the high-salt    
     purification step. The asterisk shows the range of fractions (B2-B6) in which the target  
     PEX domain should be eluted based on the molecular weight of approximately 31.51 kDa.    
     mAU = milli absorption units 
179
. 
 
 After fractionation another separation gel was run, with fractions A2-A5; B2-B6 (this 
is the portion in which the target peptide was expected to be found); B10-11; and C1-C3, 
based on the obvious peaks associated with the FPLC output. However, concentrations were 
so low that protein was very weak. A follow-up attempt to highlight the weak banding 
through silver nitrate staining was unsuccessful 
182, 183
. 
  Some fraction of the target protein is soluble (evidenced in weak, but definitive 
presence of "pure" PEX), and future attempts to adjust the conditions of the expression 
0.0
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experiments (e.g. high-salt, various other additives, temperature changes, etc.) may yield 
more usable protein. 
 
Homology Modeling of the PRG4-PEX Domain 
 
 The primary sequence of the PRG4-PEX domain peptide was submitted to multiple 
Homology Modeling portals to obtain a conjecture of the potential tertiary structure. And, 
while fully cognizant of the fact that these models are not experimentally determined 
structures, some very consistent and interesting data have emerged from the models that will 
allow further research with several intriguing hypotheses concerning the phylogenetic 
position of the PRG4-PEX domain in an evolutionary context (Figures 23 and 24). There is 
also some additional speculation as to the relevance of these data to PEX-domain evolution 
presented in Chapter 4. 
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HOMOLOGY MODELS 
 
 
Figure 23.   Homology model of the PRG4-PEX domain primary sequence, as returned by 
the Phyre2 web portal for protein modeling, prediction and analysis 
184
. The three most 
statistically relevant threads were: 1gxdA (MMP2), 1qhuA (HPX N-domain), and 2jxyA 
(MMP12). β-blades are color coded 1=purple; 2= light orange; 3=red; 4=green. Note the 
potentially unstructured blade 3 (red). 
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Figure 24.  Homology model of the PRG4-PEX domain primary sequence, as returned by 
the RaptorX web portal for protein modeling. The three most statistically relevant threads 
were: 2mqsA (MMP-14); 1genA (MMP-2); and 3ba0A (MMP-12). β-blades are color coded 
1=purple; 2= light orange; 3=red; 4=green. Note undetermined structure of blade 3 (red), 
which is consistent with Figure 23 deduced by PHYRE2 
185-187
.  
 
 
 If these models are confirmed by more robust experimental structural determination, 
then the function, if any, of the unusual (putatively unstructured) 3rd blade will be of interest.  
One possibility is that the lack of tertiary stability in some portions of the PRG4-PEX domain 
could be interpreted as a derived LOSS of structure. This in itself should prove interesting if 
the domain retained biophysical or biochemical functionality. As efforts continue to obtain a 
viable structure for this domain, experiments will also be conducted, in parallel, to determine 
its functionality. 
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HOMOLOGY MODELS: Complete PRG4 protein (Figures 25 and 26) 
 
 
 
Figure 25.   Homology model of the entire PRG4 protein primary sequence, as returned by 
the web portal I-TASSER for protein modeling, with lateral view of the structured PEX 
domain 
74, 76, 188
.  
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Figure 26.   Homology model of the entire PRG4 protein primary sequence, as returned by 
the web portal I-TASSER for protein modeling, with tangential view of the PEX domain 
showing link to primary structure of the main "body" of the protein 
74, 76, 188
. Note the 
attachment of the main body of the protein to the PEX domain is via a segment where 
structure cannot be determined at this time. 
 
Future directions:  
 
 Even though sufficient amounts to determine a structure of the PRG4 PEX domain 
peptide have not been purified to date, using E. coli recombinant techniques, experiments 
will continue until enough protein is produced to attempt crystallization of the domain. There 
are several protocols under consideration including: 
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 - Attempting the manipulation of experimental conditions to maximize yield of the 
  soluble protein obtained from these preliminary attempts. 
 
 - Expression and subsequent isolation from insoluble fractions, refolding and  
  purification 
189
. 
 
 - Attempting to express the protein in a eukaryotic cell system 
190
. 
 
 - Order the full length Lubricin protein and proteolytically cleave off the PEX domain 
  for isolation and purification 
191
. 
 
 Eventually, once sufficient amounts of protein are produced, spectrometry using the 
School of Biological Sciences High Field NMR Laboratory core facility, located on the first 
floor of the Spencer Chemistry Building, will be attempted. The available NMR spectrometer 
is a Varian Inova 600 MHz model. 
 The data obtained from spectroscopy will be processed with available computer 
modeling programs NMRPipe and NMRView 
192, 193
. Individual and backbone resonance 
assignments will be determined through the use of established NMR experimental procedures 
142, 194
. 
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CHAPTER 6 
 
EVOLUTIONARY ANALYSES OF TARGET GENES IDENTIFIED AS POTENTIAL 
GENETIC MARKERS OF COMPLICATIONS ASSOCIATED WITH  
DIET-INDUCED OBESITY 
 
Introduction 
A growing body of evidence, collated from variable analyses, has suggested there are 
numerous discoverable genetic markers that may predispose patients to the onset and 
maintenance of several human eating disorders associated with clinical obesity. 
Studies have been performed that have led to the parsing of differential effects of 
environmental versus genetic influences on growth statistics including Body Mass Index 
(BMI). A cross-sectional twin study, involving over 24,000 children from Australia, Europe 
and North America, found that variability in BMI (along with anatomical weight and height) 
was highly correlated, and influenced by genetics, across both sexes and throughout the age-
span of the participants from 5 months through adolescence (19 yoa) 
195
. 
In response to a defined North American "Obesity Epidemic", a long-term follow-up 
cohort study was performed in which parents and children who were originally assayed from 
1973-1976 were again measured 25-30 years later from 1999-2004. The results suggest that 
several important parameters including increase in adiposity and BMI levels, were 
significantly tied to genetic factors 
196, 197
. However, in another large sibling-based study, 
even though there was some evidence for differences in the heritable effects of birth weight 
in the adolescent years based on sex of the child, there may also be differential effects of 
intrauterine environmental conditions that remain to be explained 
198
. 
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Empirical evidence is mounting on the significant impacts of a variety of genetic 
modalities on heritable obesity pathologies, including monogenetic, polygenetic and 
mutational influences. Genetic disruption of energy balance of the leptin/melanocortin 
pathway and compromised differentiation of the paraventricular nucleus in neurons have 
been shown to involve defects in at least eight genes with the potential of leading to the 
development of monogenetic obesity in humans 
199
. Studies on inherited polygenic 
susceptibility to obesity have implicated disruption of normal body weight regulation of CNS 
function
200
. In whole-exome sequencing analyses within families with a pedigree for two 
relatively common and severe eating disorders (EDs), anorexia nervosa and bulimia nervosa, 
the pathologies were shown to be correlated with rare missense mutations in both the histone 
deacetylase 4 (HDAC4) gene and the estrogen-related receptor α (ESRRA) gene201. Direct 
secretory biochemical involvement in the development of various obesity syndromes is also 
well documented. Abnormal levels of dopamine, norepinephrine and serotonin have been 
noted in clinical experiments with people suffering from a wide spectrum of eating disorder 
related obesities 
201
. 
The protein product of the vgf (non-acronymic) gene is a secreted neuropeptide 
precursor shown to be synthesized and proteolytically modified in mammalian neurons 
202
. A 
multitude of neuroendocrine roles have been empirically shown to be associated with several 
specific peptide derivatives of the VGF precursor protein, including TLQP-21 
203-205
. Work 
with this peptide has uncovered links between metabolic energy budgets and food intake rate 
in mouse 
206-208
. The TLQP-21 peptide is a downstream derivative of its larger TLQP-62 
precursor which elicits a dose-dependent increase in energy expenditure in rats 
203, 204
. 
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Several other VGF derived peptides including NERP-1, NERP-2 and NERP-4 have been 
shown to be bioactive, but their respective functions have not been fully elucidated 
202, 205, 209
. 
 Experiments with intraventricular infusions of TLQP-21 in Siberian hamsters induced 
weight loss attributed to decreased food consumption. That same series of experiments also 
showed that VGF deficient mice exhibited shorter circadian periods, suggesting these 
secretions play a role in influencing superchiasmatic regulation of food intake patterns 
210
. 
The TLQP-21 peptide has also been correlated with increases in UCP-1 (Uncoupled Protein - 
1), a white adipose fat tissue secretion, and concomitantly shown to mitigate some negative 
effects during high-fat diet experiments with mice 
205, 211, 212
. 
Recent work has used genetic information obtained from the Gene Expression 
Omnibus (GEO), a public access genomic information repository coordinated and maintained 
through the National Center for Biotechnology Information (NCBI) 
129, 213
. The experiment 
involved using the GEO subroutine algorithm GEO2R that can be programed to search for 
expression data based on predesignated correlation parameters 
214
.  The initial screen in this 
experiment targeted several genes, including the VGF gene, which had been previously 
identified as being involved in the regulation of several metabolic processes broadly linked to 
eating disorders, and more specifically to Night Eating Syndrome (NES). This particular 
condition is characterized by behaviors that involve eating substantial amounts of post 
evening meal calories (>25%) either before the patient can fall asleep, or waking to consume 
the additional food shortly after falling asleep and the inability to return to sleep until the 
late-night eating episode has occurred 
215
. While NES is not manifested in all cases, it is seen 
in a substantial number of patients with diagnosed clinical obesity, and it has been proposed 
95 
that the condition is potentially driven by genetically mediated breakdown in normal 
metabolic, circadian or neuronal control 
216
.  
The genetic screens were performed under the assumption that metabolic as well as 
neuronal factors might influence the development of NES 
213
. A second level of identification 
involved parallel screening between multiple gene libraries to determine if any genes 
registered as significant hits across datasets 
213
. This analysis resulted in the identification of 
6 genes (in addition to VGF) that tested statistically significant for the original cross 
correlates
213
. Those 6 genes were:  ATPase 1 α-3 (Atp1a3); B930041F14Rik (a murine gene 
with a human ortholog: FNDC10 - FibroNectin type-III Domain-Containing transmembrane 
protein); Deformed Epidermal Auto-regulatory Factor 1 (DEAF1); Insulin like Growth 
Factor Binding Protein 2 (IGFBP2); RNA binding motif protein 3 (Rbm3); and X-box 
binding protein 1 (Xbp1). This work is a follow-up evolutionary analysis of these 6 gene 
candidates that are implicated in mechanisms associated with NES. 
 
Genes of interest 
 
During a broad screening search of the Gene Expression Omnibus (GEO) for 
potential candidate genes associated with a human eating disorder (Night Eating Syndrome - 
NES), in addition to the primary hits, there were six genes that showed significance across 
more than one dataset in relation to the established search parameters of involvement in 
neural development, plus, sleeping/eating disorders 
213
. 
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Atp1α3 - ATPase Na+/K+ transporting subunit alpha 3 [Homo sapiens (human)] 
 
 The product of this gene is the alpha-3 component of a two subunit, integral 
membrane enzyme belonging to the P-type cation transporter ATPases, sub-family Na
+
/K
+
 -
ATPases. Its primary function is to establish and maintain cross-membrane electrochemical 
gradients of sodium and potassium ions, necessary for electro-excitability of muscle and 
nerve tissues, sodium coupled molecular transport, and osmoregulation. Malfunctions in this 
protein have been associated with a suite of human disorders including hyper-excitability of 
the central nervous system (CNS) and alternating hemiplegia of childhood 
217, 218
. 
 
DEAF1 - Deformed Epidermal Autoregulatory Factor 1 - a.k.a. - suppressin [H. sapiens] 
 
 This gene encodes a zinc finger transcription factor. The protein binds to several 
secondary target genes as well as to its own promoter. It is known to downregulate 
transcription of the HNRPA2B1 (Heterogeneous Nuclear Ribonucleoprotein A2/B1) gene 
219
.  
It also binds RARE (the retinoic acid response element), and activates both PENK (the 
preproenkephalin gene) and EIF4G3 (Eukaryotic translation initiation factor 4 gamma 3) 
220-
222
. In mouse models, defects in availability of DEAF1 were shown to compromise 
embryogenesis by disrupting skeletal patterning and neural tube closure 
223
. Mutations in the 
SAND (Sp100, AIRE-1, NucP41/75, DEAF-1) domain of the DEAF1 gene have recently 
been shown to cause a form of an autosomal dominant condition marked by aberrant 
behavioral patterns, severe speech impairment, and intellectual disability 
224
. Additionally, 
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DEAF1 has been implicated in several pathologies including colorectal cancer, and perhaps 
most significantly for the purposes of these analyses, type-1 diabetes 
225, 226
. 
 
FNDC10 - fibronectin type III domain containing 10 [H. sapiens] 
 
 In the original screen, this hit was identified as a murine gene from Mus musculus 
(house mouse) designated B930041F14 
213
. It is also known as C1orf233, and the human 
ortholog designation is FNDC10. The gene codes for a 226 aa trans-membrane protein. There 
is no primary literature associated with the functionality of this protein. 
 
IGFBP2  - insulin-like growth factor binding protein 2 [H. sapiens] 
 
 This gene encodes a protein with several known transcript variants that can either be 
secreted to bind insulin-like growth factors I and II (IGF-I and IGF-II) in the bloodstream 
with high affinity or, it can persist intracellularly where it interacts with a variety of differing 
ligands 
227
. It has been shown to be a player in a variety of human pathologies including 
kidney disease, ventricular stroke, Pallister-Killian Syndrome (PKS), and several cancers 
including esophageal, breast and colorectal 
228-233
. It has also, on a positive note, recently 
been implicated in the potential moderation of dementia-relevant, age-specific deterioration 
of cognitive function 
234
. 
 
 
 
98 
Rbm3 - RNA binding motif (RNP1, RRM) protein 3 [H. sapiens] 
 
 The protein derived from this gene is a member of a family of proteins containing at 
least one RNA recognition motif domain (RRM). Translation is stimulated via low oxygen 
tension and/or cold shock 
235-237
. There are several splice variants of this gene that lead to the 
translation of multiple isoforms, and these have been differentially categorized as having 
myriad effects on human disease progression both positively and negatively 
238
. For example, 
measures of decreased expression have been shown to correlate with tumor growth and poor 
disease prognosis in patients suffering from urothelial bladder cancer, and increases in 
nuclear expression have been connected to improvements in prognosis with colorectal  
cancer 
239, 240
. This gene is an X chromosome associate and is known to have a pseudogene 
copy located on human chromosome 1. 
 
Xbp1 – X-box binding protein 1 [H. sapiens] 
 
 The functional gene is located on Chromosome 22 in humans and codes for a 
transcription factor in Basic Leucine Zipper Domain (bZIP) protein family 
241, 242
. There 
exists also a known pseudogene located on chromosome 5
241
. The name refers to the property 
of the protein binding to a particular promoter sequence known as an X-box 
243
. A primary 
function is the regulation of the Unfolded Protein Response (UPR) during stress events in the 
endoplasmic reticulum (ER) 
244, 245
. The obligatory need for proper expression of this protein 
during embryogenesis in mouse has been demonstrated, particularly with respect effectual 
development of heart, liver, endocrine pancreas, salivary gland and secretory tissues 
246
. 
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 The human XBP1 protein is known to be expressed as two isoforms designated as 
XBP1 spliced (XBP1s), and XBP1 unspliced (XBP1u) 
247
. The two isoforms are 
differentially but significantly involved in numerous human physiological processes 
including adipogenesis and lipogenesis 
248, 249
. There are also numerous human pathologies in 
which this protein has been shown to play a crucial role, such as atherosclerosis, ischemia 
and a variety of cancers, including, but not limited to breast, multiple myeloma (MM), and 
osteosarcoma 
250-253
. Conversely, there is also modeling data to suggest that the functioning 
of XBP1s during ER stress provides some protection against β-amyloid neurotoxicity in the 
progression of Alzheimer's Disease (AD) 
254
. Additionally, and more significantly for the 
purposes of this work, mice with an induced deficiency in XBP1 protein became insulin 
resistant and developed type-2 diabetes, apparently as a function of obesity-linked ER  
stress 
255
.  
 
Methods and Results 
 
Evolutionary analyses 
 
 Sequences for all available human variants of each of the target genes, and one 
sequence each from Macaca, were accessed through the NIH-NCBI public genomics 
database repository (henceforth simply: NCBI) 
32
. Coding sequences for all genes used in the 
analyses were verified using the BLAT function of the University of California - Santa Cruz 
Genome Browser 
256, 257
. 
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 To assess potential functional consequences of mutation at the protein level, known 
nucleotide polymorphisms for each of the human target genes were obtained from the dbSNP 
portal of the NCBI, which catalogs research-identified single nucleotide polymorphisms 
(SNPs)
47
. Each of the genes was subsequently screened using the SNPNexus portal of the 
Barts Cancer Institute at Queen Mary University of London 
258
. Individual SNPs are 
identified using a standard protocol known as "rs" numbers in the NCBI dbSNP database. 
The rs-numbers were obtained and copied into the analysis window at the SNPNexus site and 
screened through two in silico programs SIFT and PolyPhen-2 
259, 260
. Both programs operate 
through algorithms that are designed to predict the potential functional impact of specific 
missense amino acid substitutions and score them numerically. The SIFT method score the 
substitutions on a mathematically standardized scale from 0 to 1. If a substitution scores  
≤ 0.05 it is considered "damaging".  Any score > 0.05 is deemed "tolerated". In the 
PolyPhen-2 program, scores are standardized to a range of 0 to 1 but are differentially 
designated as "probably damaging", "possibly damaging" or "benign". In PolyPhen-2, the 
higher the score, the more potentially damaging is any particular substitution. It is generally 
agreed in the field, that for a substitution to be considered deleterious with a high level of 
confidence, it should be predicted as potentially, functionally damaging by at least two 
independent methods (Figure 27).  
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Figure 27. Proportional number of missense (nonsynonymous) mutations effects on the 
potential functionality of the resulting protein products of each target gene. Categories are 
defined as either "Tolerated" or "Damaging" when both SIFT and PolyPhen-2 prediction 
algorithms concur as to the functional consequences of any specific SNP. Ambiguous 
mutations, and category "unknown", are not represented on this graph. 
 
Atp1a3- There are a total of 78 SNPs currently reported for this gene. SIFT/PolyPhen 
combined identified 60 (77%) of these as being damaging, and 18 (23%) as tolerated. This 
result is consistent with high levels of evolutionary constraint. 
 
DEAF1 - There are a total of 33 SNPs currently reported for this gene. SIFT/PolyPhen 
combined identified 15 (42%) of these as being damaging, and 18 (58%) as tolerated. This 
can be interpreted as this protein having functional plasticity that potentially allows for some 
level of polymorphic selection. 
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IGFBP2 - There are a total of 11 SNPs currently reported for this gene. SIFT/PolyPhen 
combined results identified 8 (73%) of these as being damaging, and 3 (27%) as tolerated. 
This suggests constraint, but the small sample size is a concern for proper interpretation. 
 
Xbp1 - There are a total of 43 SNPs currently reported for this gene. SIFT/PolyPhen 
combined identified 20 (46.5%) of these as being damaging, and 23 (53.5%) as tolerated. 
Similar to DEAF1 this pattern can be interpreted as this protein having functional plasticity 
that potentially allows for some level of polymorphic selection. 
 
Rbm3 - There are a total of 8 SNPs currently reported for this gene. SIFT/PolyPhen 
combined identified 4 (50%) of these as being damaging, and 4 (50%) as tolerated. The even 
distribution and limited information on this gene render any broad-scale assumptions suspect. 
 
Statistical analyses 
 
 To explore comparative evolutionary rates of each of the target genes, the McDonald-
Kreitman Test (MKT) was run on each to compare synonymous vs. nonsynonymous amino 
acid substitutions within human genes, and between humans (Homo sapiens) and the Rhesus 
macaque (Macaca mullata) 
261
. The Rhesus macaque was chosen for the comparisons 
because it is a relatively close primate lineage to Homo, but with sufficient time since 
divergence to show a robust number of between-species fixed genetic differences. 
Additionally, M. mullata has a substantial amount of genomic data available for 
comparisons.  
103 
 The basal within-species variation for the synonymous and nonsynonymous changes 
(missense mutations) for the human genes were attained through the dbSNP search protocol 
of the NCBI 
32
. They were subsequently validated through the 1000 Genomes Project 
48
. The 
statistical significances of the MKT were evaluated using the Fisher's Exact Test (FET) for a 
2x2 contingency table. The between-species comparisons (Homo x Macaca), involved 
aligning the coding nucleotide sequences of both using the MEGA6 package's ClustalW 
function and transferring the alignments to the MKT program for statistical analyses 
261-263
. 
Probability values (p) were considered statistically significant with α < 0.05, Table 10. 
 
Table 10: Results of MKTs. Statistical significance was assessed by Fisher's Exact Test for a 
2x2 contingency table. 
 
 
NI
a
 p-value Variation Gene Nonsynonymous Synonymous Total Interpretation 
    
Atp1a3 
    
VERY strong  
constraint   Within Species Variation 
b
  19 10 29 
9.393 p < 0.001* Fixed species differences c  20.10 99.38 119.48 
  Total  39.1 109.38 148.48 
    
DEAF1 
    
Strong positive 
selection   Within Species Variation 
b
  25 10 35 
5.973 p = 0.014* Fixed species differences c  37.92 3.01 62.92 
  Total  62.92 13.01 75.93 
    
FNDC10 
    
Neutral 
  Within Species Variation 
b
  1 0 1 
NULL p = 0.536 Fixed species differences c  84.06 32.20 116.26 
  Total  85.06 32.20 117.26 
    
IGFBP2 
    
Weak positive  
selection?   Within Species Variation 
b
  45 24 69 
0.583 p = 0.087 Fixed species differences c  113.95 35.44 158.95 
  Total  158.95 59.44 218.39 
    
Rbm3 
    
Constraint? 
  Within Species Variation 
b
  84 22 106 
NULL p = 0.006* Fixed species differences c  0.00 2.04 2.04 
  Total  84 24.04 108.04 
    
Xbp1 
    
Neutral 
  Within Species Variation 
b
  7 2 9 
2.045 p = 0.400 Fixed species differences 
c
  26.34 15.39 41.73 
  Total  33.34 17.39 50.73 
 
a 
Neutrality Index (NI) as computed with Jukes & Cantor correction for divergence; 
b 
all known mutations within humans;  
c
 values converted under JC69 model; * statistically significant at α < 0.05. 
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Phylogenetic analyses 
 
Atp1a3  
 
 The evolutionary relationships of the Atp1a3 protein within selected primates, rooted 
by a murine clade, was inferred by using the Maximum Likelihood method based on the JTT 
matrix-based model 
82
. The bootstrap consensus tree inferred from 500 replicates is taken to 
represent the evolutionary history of the taxa analyzed 
83
. Branches corresponding to 
partitions reproduced in less than 50% bootstrap replicates are collapsed. The percentage of 
replicate trees in which the associated taxa clustered together in the bootstrap test (500 
replicates) are shown next to the branches 
83
. Initial tree(s) for the heuristic search were 
obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of 
pairwise distances estimated using a JTT model, and selecting the topology with superior log 
likelihood value. The analysis involved 13 amino acid sequences. All positions containing 
gaps and missing data were eliminated. There were a total of 968 potential amino acid 
positions in the final dataset. Evolutionary analyses were conducted in MEGA7 
81
.  Below is 
the best supported phylogeny for Atp1a3 (Figure 28). 
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Figure 28. Molecular Phylogenetic analysis by Maximum Likelihood method for Atp1a3 
protein.  
 
 The placement of Homo sapiens on this phylogeny was at first confusing, in that 
humans would normally be expected to fall in a tight clade with common chimp, bonobo, 
gorilla and orangutan, the "classic" great apes. However, this result places P. troglodytes and 
H. sapiens outside that group and clades them with the sooty mangabey, and Colobus (both 
old world monkeys), and clades bonobo, gorilla, orangutan and Papio anubis (the Olive 
baboon) together, with the baboon being somewhat of an unexpected member there. 
However, upon detailed investigation of the alignment of the proteins it is very obvious that 
these clades are real, as also evidenced by the high statistical support for the root branches of 
both clades. The two clades diverge from one another in several locations along the length of 
the alignment but the pattern between clades is remarkably consistent, Table A5, 
APPENDIX I.  
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 One hypothesis based on this observation is that this may be an example of a multiple 
domain level functional convergence in the operations of this otherwise highly constrained 
protein that has led to a phylogenic "split" in the great apes. While this result seems 
unconventional, there is a well-documented level of incongruence, or mismatch, between 
established species-trees and more contemporarily deduced gene-trees to the point that 
evolutionary relationships within the Hominoidea (apes) still remains somewhat contentious 
264-266
. Although, most cladistic analyses done on genomic sequences support the traditional 
morphological relationships within the clade (Pan and Homo as sisters, Gorilla as outgroup); 
there are known independent DNA sequence data sets that resolve the clade differentially. 
Two such sets support a Pan- Gorilla clade and one suggests a Homo-Gorilla clade 
264
. One 
major significance of this is to lend credence to the phylogeny presented here, as a function 
of a single gene product (Atp1a3) analysis. This observation will be a major focus of future 
evolutionary and functional analyses of this specific protein. 
 
DEAF1 
 
 The evolutionary history of the DEAF1 protein was inferred by using the Maximum 
Likelihood method based on the JTT matrix-based model. The bootstrap consensus tree 
inferred from 500 replicates is taken to represent the evolutionary history of the taxa 
analyzed 
82
. Branches corresponding to partitions reproduced in less than 50% bootstrap 
replicates are collapsed. The percentage of replicate trees in which the associated taxa 
clustered together in the bootstrap test (500 replicates) are shown next to the branches 
82
. 
Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join 
107 
and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and 
selecting the topology with superior log likelihood value. The analysis involved 13 amino 
acid sequences. All positions containing gaps and missing data were eliminated. There were 
a total of 176 potential amino acid positions in the final dataset. Evolutionary analyses were 
conducted using MEGA7 
81
.  
 Orangutan (Pongo) was excluded from the DEAF1 analysis due to lack of a full 
length predicted protein in the database 
33
. Not much of scientific value can be inferred from 
this phylogeny due to the lack of adequate statistical support for several nodes. This is 
certainly a consequence of the lack of robust information contained currently in the database 
pertaining to the DEAF1 protein (Figure 29).  
 
 
 
Figure 29. Molecular Phylogenetic analysis of the DEAF1 protein by Maximum Likelihood 
method. 
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 Although not able to follow up with more in-depth evolutionary analysis, at this time, 
a puzzling contradiction of the results obtained regarding IGFBP2 is that it falls out in the 
MKT as being potentially under positive selection (albeit weak) but the SNP analyses 
suggests a high level of functional intolerance of mutations, which would more typically be 
associated with evolutionary constraint. However, this may simply be an artifact of there 
being so few known SNPs (11) for this gene. Again, obviously, more information is needed 
on the true level of polymorphisms of this gene on a larger population basis to be able to 
reasonably pursue this observation 
 Unfortunately, the remaining 4 proteins of interest: FNDC1, IGFBP2, Rbm3, and  
Xbp1, fall into the same category as DEAF1 in that there is not enough reliable sequence 
information currently available in the databases to allow for robust phylogenetic analyses. 
These proteins, therefore will remain a part of future pursuits as regards these principles of 
association, and await further research, updates and bioinformatic annotations. 
 
Discussion 
 
 Six genes were identified in previous work that mined the Gene Expression Omnibus 
(GEO) database to search for genes that correlated highly with specific input parameters 
associated with disruption of metabolic processes implicated in, broadly, "eating disorders"; 
and specifically, with "Night Eating Syndrome" (NES) 
129, 213-215
. This survey identified one 
specific gene (VGF) as being highly correlated with the search parameters. However, also 
recognized in those analyses there were an additional six genes identified across and between 
several differing gene libraries, that while not directly implicated in NES, did show high 
109 
levels of association with the metabolic and neuronal pathways associated with eating 
disorders in general 
213
.  These six genes Atp1a3, C1orf233, DEAF1, IGFBP2, Rmb3, and 
XBP1 were earmarked for further evolutionary analyses. 
 As a result of the combined evolutionary and phylogenetic analyses focus has been 
applied to current and continued efforts on the three genes that appear to be most 
consequential from an evolutionary stand point: Atp1a3 for apparently being under very 
strong selective constraint, DEAF1 for its high indication of positive selection, and IGFBP2 
for its apparent lack of tolerance to non-synonymous substitutions. Although the remaining 
genes, for analytical and/or sparse information reasons, are excluded in this current pursuit, 
deeper evolutionary investigation may be warranted in the future to help establish values of 
background selection potentially operating on the entire suite of genes associated with 
evolution driven by changes in human shifts in dietary behavior. 
 As with the previous study focusing on VGF, it is assumed that eating disorders that 
lead to obesity are most certainly polygenic conditions. It is therefore important to attempt to 
understand each of these genes individually, as well as to try and determine if there are any 
deeper order interactions that may be a consequence of combinations involving allelic 
variations. One method for attempting to address this complexity would be to set up 
comparisons between clinically obese individuals that do not exhibit NES with those that are 
obese and engage in NES behaviors. This could potentially lead to insights regarding 
interactions and synergisms between and within the various allelic combination of the 
subject's genomic compliment of SNPs. Although, again, as suggested in the previous work, 
the "treatment" categories of such an experimental setup would pose significant problems 
110 
because behavioral patterns, especially regarding night eating habits, may be very difficult to 
parse and control for 
213
.  
 However, these types of analyses would be of value in potentially establishing 
emergent relationships between the various genes in question. As a case in point, 
transcription and expression of VGF in the suprachiasmatic nucleus (SCN) is apparently 
regulated by circadian modulation 
267
. If it could be established that any of these other gene 
products are under similar regulatory control, then it may be possible to begin to link the 
combined effects of the various individual players to the phenotypes in question, in this case 
behaviors associated with eating disorders and the onset of obesity related pathologies. 
 An underlying working hypothesis for the pursuit of these genetic screens and 
subsequent evolutionary analyses is that these designated gene candidates are all in some 
way connected to metabolic modulation and so will potentially negatively influence the 
metabolic pathways that control "normal" eating cycles, and consequentially lead to weight 
gain and an eventual obese condition. Deep analysis of patients who can be shown to carry 
multiple damaging polymorphisms across the entire suite of these implicated genes should 
give us insights in the genetic foundation of the propensity of these individuals to engage in 
aberrant eating behaviors. 
 As with the VGF study there are several cautionary issues to be considered in any 
analyses of these types going forward. First, the knowledge that these various polymorphisms 
exist in the target genes must be considered when screening participants for experimental 
cohorts. The genomes of any individuals considered for control groups must be evaluated to 
ensure the absence of the allelic mutations. And, as previously noted, this will present a 
111 
particularly challenging set of criteria for obesity related diseases due to the probable high 
level of concurrence within many potential research populations 
213, 268
. 
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APPENDIX A 
 
SUPPLEMENTAL INFORMATION ON 4-BLADED β-PROPELLER DOMAIN 
CONTAINING PROTEINS 
 
Table A1.   List of proteins used to describe forms of known multiple β-blade domains for 
which structures exist to accompany Figure 1. 
 
 
NAME OF 
PROTEIN 
 
 
NUMBER 
OF BLADES 
 
 
FOUND IN 
(organisms) 
 
 
FUNCTION OF 
DOMAIN 
 
Hemopexin, 
MMPs, PRG4, 
VTN, WAPs 
 
4 
Bacteria; 
Eukarya 
Variable 
(see text) 
Tachylectin-2 5 
Japanese 
horseshoe crab 
Innate immunity: glycol- 
recognition of pathogens 
269
 
 
1-RWL 
(Sensor 
domain of the 
receptor 
Ser/Thr 
protein kinase) 
 
6 
 
Mycobacterium 
tuberculosis 
 
Transmembrane receptor  
Ser/Thr protein kinases 
270
 
 
RACK-1 
(Receptor of 
activated 
protein C 
kinase 1) 
 
7 
 
 
Prokaryotes; 
Eukarya 
 
 
The Receptor for Activated  
C Kinase 1 
271
 
 
4ZOX 
(Ribosome 
assembly 
protein SQT1) 
 
8 
 
Saccharomyces 
cerevisiae 
 
Ribosomal assembly  
Protein 
272
 
 
3F6K 
(Sortilin) 
 
10 
 
Homo 
 
Protein transport,  
primarily neuronal 
273
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Table A2.   Comparison of sequence identity of human hemopexin with other species 
represented in the NCBI database. 
 
 
 
SPECIES 
 
(%) Identity of protein 
primary amino acid 
sequence 
 
 
(%) Identity of DNA 
nucleotide sequences 
Homo sapiens 100.0 100.0 
Common Chimp 99.8 99.7 
Dog 81.9 85.9 
Cow 73.8 81.1 
Rat 77.2 82.6 
Mouse 75.9 81.9 
Chicken 58.3 62.8 
Zebrafish 38.1 50.0 
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APPENDIX B 
 
LIST OF THE HUMAN MMPs INCLUDED IN THE PHYLOGENIES ALONG WITH A 
BRIEF DESCRIPTION OF KNOWN FUNCTIONALITY 
 
Table A3. Detailed descriptions of human Matrix Metalloproteinases (MMPs) used in 
phylogenetic analyses. 
 
Protein (alias) Primary known functions 
Extra/inter 
cellular 
Conserved in:   (non-
exhaustive) 
    
MMP1 
(interstitial 
collagenase) 
Breakdown of interstitial collagens I,II,III,VII, 
and X, and viral Tat Protein 
secreted Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken 
MMP2 
(gelatinase A) 
Vascular remodeling, angiogenesis, tissue 
repair, tumor invasion, inflammation, 
atherosclerotic plaque rupture. Degradation of 
extracellular matrix proteins and several non-
matrix proteins, cleaves KISS at Gly-|-Leu 
bond. Role in myocardial cell death, cleaves 
GSK3β, formation of fibrovascular tissues with 
MMP14, anti-angiogenic and anti-tumor 
properties, inhibits cell migration and cell 
adhesion to FGF2 and Vitronectin. Ligand for 
integrin/β-3 on blood vessel surface. 
Intracellular and 
secreted 
Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish, 
and frog 
MMP2 
 (Isoform) 
Mediates proteo-CHUK/IKKA, activation of 
NF-kappaβ, NFAT, and IRF transcriptional 
Pathways 
not known (N/K) Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish, 
and frog 
MMP3 
(stromelysin-1) 
Degradation of fibronectin, collagens III, IV, 
IX, X, gelatins I,III,IV, and V, and cartilage 
proteoglycans. Activates pro-collagenase 
N/K Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, and frog 
MMP8 
(neutrophil 
Collagenase) 
Degradation of collagens I, II, and III. N/K Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat and zebrafish. 
MMP9 
(gelatinase B) 
Implicated in local proteolysis of the ECM; 
leukocyte migration; resorption of bone 
osteoclasts. Cleavage of KiSS1 at a Gly-|-Leu 
bond. Cleavage of type IV and type V collagen 
into 3 C-terminal quarter fragments and 1 
shorter N-terminal quarter fragment; 
degradation of fibronectin (but not: laminin or 
Pz-peptide) 
secreted Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish, 
and frog 
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MMP10 
(stromelysin-2) 
 
Degradation of gelatins type I, III, IV, and V; 
and weakly collagens III, IV, and V. Activates 
pro-collagenase. 
N/K chimpanzee, Bonobo, Rhesus monkey, 
mouse, rat and chicken 
MMP11 
(stromelysin-3) 
Cleaves alpha 1-proteinase inhibitor, degrades 
structural extracellular matrix proteins. 
secreted Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat,  
chicken, zebrafish, and frog 
MMP12 
(macrophage 
elastase) 
Degradation of soluble and insoluble elastin. 
Cleavages at 14-Ala-|-Leu-15 and 16-Tyr-|-Leu-
17 in the B chain of insulin. Accepts large and 
small amino acids with preference for leucine at 
P1' site. Aromatic and hydrophobic residues 
preferred at the P1 site, small hydrophobic 
residues (alanine) occupying P3. 
N/K Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, and rat 
MMP13 
(collagenase 3) 
Substrates include Col I, II, III, IV, IX, X, XIV, 
gelatin 
secreted 
 
 
MMP14 
(transmembrane) 
MT-MMP 1  
Cleaves PTK7. Activates progelatinase A and 
MMP15 
cell surface Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, zebrafish, fruit fly, 
mosquito, C. elegans, and frog. 
MMP15 
(transmembrane) 
MT-MMP 2 
Endopeptidase degrades various extracellular 
matrix. Activates progelatinase A. 
cell 
surface/secreted 
Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish. 
MMP16 
(transmembrane) 
MT-MMP 3 
Endopeptidase degrades various extracellular 
matrix. Activates progelatinase A. Matrix 
remodeling. Isoform cleaves fibronectin and 
collagen III. Degradation of Type I collagen 
with interaction from CSPG4. 
secreted Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish, 
and frog 
MMP17 
(transmembrane) 
MT-MMP 4 
Endopeptidase degrades various extracellular 
matrix including fibrin. May activate growth 
factor precursors and inflammatory mediators 
such as necrosis factor-alpha. May be involved 
in tumoral process. Does NOT hydrolyze 
collagens I, II, III, IV, and V; gelatin, 
fibronectin, laminin, decorin, nor alpha1-
antitrypsin. 
membrane bound Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish, 
fruit fly, mosquito, C. elegans, and frog. 
MMP19 
(stromelysin- 4) 
Endopeptidase degrades various extracellular 
matrix components including aggrecan and 
cartilage oligomeric matrix protein. May take 
part in neovascularization and angiogenesis. 
Hydrolyzes Collagen IV, laminin, nidogen, 
nascin-c isoform, fibronectin and gelatin I. 
extracellular Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, zebrafish, and frog. 
MMP20 
(enamelysin) 
Degrades amelogenin. Major enamel 
component and macromolecules aggrecan and 
COMP. 
N/K Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, zebrafish, and frog. 
MMP21 
(X MMP) 
May play role in embryogenesis, especially in 
neuronal cells, and lymphocyte development 
and survival.  
N/K Chimpanzee, Bonobo, Rhesus monkey 
dog, mouse, rat, zebrafish, and frog 
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MMP24 
(MT-MMP 5) 
Mediates cleavage of N-cadherin and regulates 
neuro-immune interactions and neural stem cell 
quiescence. Involved in cell-cell interactions 
between nociception and inflammatory 
hyperalgesia. Mediates cleavage of CDH2. May 
contribute to axonal growth. Activates 
progelatinase- A. May be a proteoglycanase 
involved in degradation of proteoglycans           
(dermatan sulfate and chondroitin sulfate) 
partially cleaves gibronectin. 
membrane bound Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, chicken, zebrafish, 
and frog. 
MMP25 
(MT-MMP 6) 
Degrades casein. Possible role in tissue 
homeostasis and repair. 
membrane bound Chimpanzee, dog, cow, mouse, zebrafish, 
mosquito, and frog 
MMP27 
(MMP-22, C-MMP) 
Matrix metalloproteinases degrade extracellular 
components such as fibronectin, laminin, 
gelatins, and collagens. 
N/K Chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, and chicken 
MMP28 
(epilysin) 
Degrades casein. Possible role in tissue 
homeostasis and repair. 
secreted chimpanzee, Bonobo, Rhesus monkey, 
dog, cow, mouse, rat, and chicken 
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APPENDIX C  
 
PRIMARY SEQUENCE IDENTITY BETWEEN VARIOUS PEX DOMAINS (HPX, 
MMPs, PRG4, VTN) GENERATED VIA DIRECT PAIRWISE ALIGNMENTS 
33
 
 
Table A4.   Primary sequence identity between various PEX domains (HPX, MMPs, PRG4, VTN).  
* In the context of sequence alignments, a "score" is a relative numerical value that describes the 
overall quality of an alignment. Higher numbers correspond to higher similarity 
33
. 
 
 
HPX 
domain  
HPX-N  HPX-C  
Max 
score* 
Total 
score* 
Query 
cover 
E- 
Value 
Ident 
Max 
score* 
Total 
score* 
Query 
cover 
E- 
Value 
Ident 
MMP1 52.0 119 87% 1e-12 27% 45.1 137 71% 4e-10 36% 
MMP2 46.2 130 96% 2e-10 25% 46.2 144 80% 3e-10 31% 
MMP3 51.6 113 97% 2e-12 31% 43.5 147 69% 1e-09 25% 
MMP8 52.8 164 98% 8e-13 26% 43.1 138 81% 2e-9 24% 
MMP9 32.3 182 93% 9e-06 31% 33.1 96.6 91% 7e-06 25% 
MMP10 63.5 108 98% 1e-16 32% 42.4 163 90% 3e-09 24% 
MMP11 56.2 101 95% 5e-14 28% 26.6 121 81% 5e-04 29% 
MMP12 58.9 90.1 87% 6e-15 30% 41.2 97.0 66% 9e-09 25% 
MMP14 45.1 156 95% 4e-10 23% 39.3 128 79% 4e-08 25% 
MMP15 53.5 151 96% 7e-13 27% 32.7 167 90% 7e-06 23% 
MMP16 53.1 150 95% 7e-13 25% 32.3 122 81% 9e-06 28% 
MMP17 57.8 109 99% 2e-14 28% 33.9 101 62% 3e-06 26% 
MMP19 57.4 104 95% 2e-14 31% 36.6 119 81% 3e-07 24% 
MMP20 45.1 139 96% 3e-10 29% 28.1 92.8 87% 2e-04 24% 
MMP21 39.7 140 85% 2e-08 41% 41.2 82.4 64% 1e-08 26% 
MMP24 49.7 144 97% 1e-11 26% 30 88.5 97% 6e-05 28% 
MMP25 28.9 111 95% 9e-05 24% 35.8 151 95% 6e-07 29% 
MMP26 21.9 135 76% 0.011 39% 14.2 14.2 6% 2.4 46% 
MMP27 48.9 63.5 87% 2e-11 25% 40.4 83.2 73% 2e-08 24% 
MMP28 37.7 123 94% 1e-07 30% 40.0 97.4 81% 2e-08 31% 
PRG4 47.4 161 85% 2e-10 29% 27.3 27.3 49% 8e-04 26% 
VTN 52.4 177 99% 1e-12 31% 39.7 143 80% 3e-08 29% 
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APPENDIX D 
 
PRIMARY SEQUENCE AND HOMOLOGY MODEL OF THE PROTEIN LIMUNECTIN 
FROM HORSESHOE CRAB 
Primary sequence:  
 
MFILKGMWTFLLLAILQISTCEVSQTDKTELHSTGMEILQSIFPSIDAVFKWSNGVTYIFKGSCYFRY
EDKTNEISNCRRLSAWGGLTGPVDAVFRWRNGVTYFFQGDCYYRYEDKTDEISKCSPVTAWGGMTGPV
DAVFRWSNGITYFFKEDCYYRYEDKDNKISKCTPITAWGKMTGPIDAVFRWSNGVTYFFKRDCYFRYE
DKPNEISKCRAIALWGASSYQPLDAVFRWNDGVTYFFKGFCYYHNDLKKCKPISAWGGISKPVSAVLL
WNNKETYFFEGKCYHSYEAKNNSISKCIPISTWAKKIRVVDAVFRWSNGITYFFKGDCYYRYEDKTNK
LSQCSPVTEWGGMTGPVDAVFRWSNGATYFFQGNCYYRYDDKNNKLSQCSPVTAWGGMTGPVDAVFRW
SNGATYFFKEDCYMKYEDKPQKLSGCNPISAWGGGIY 
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APPENDIX E 
 
PRG4 - PEX-DOMAIN DNA NUCLEOTIDE SEQUENCE (SHOWN AS CODONS) USED 
FOR ORDERING OF THE GBLOCK FOR CLONING, EXPRESSION AND 
PURIFICATION 
 
5'- CCG AAC CAG GGC ATT ATC ATT AAT CCT ATG CTT AGC GAT GAG 
ACG AAT ATC TGC AAT GGT AAA CCG GTG GAC GGC TTG ACG ACC CTG 
CGC AAC GGT ACT CTC GTG GCG TTC CGC GGC CAT TAC TTT TGG ATG 
TTG TCT CCG TTT TCA CCA CCA TCC CCG GCG CGC CGC ATT ACC GAG 
GTA TGG GGT ATC CCA AGC CCG ATT GAT ACG GTG TTT ACG CGT TGC 
AAC TGT GAA GGT AAA ACT TTT TTC TTT AAA GAC AGC CAG TAT TGG 
CGC TTT ACC AAT GAC ATT AAA GAT GCC GGC TAT CCC AAG CCT ATC 
TTC AAA GGA TTT GGT GGC CTG ACA GGC CAA ATT GTT GCA GCG CTG 
TCT ACG GCT AAA TAC AAA AAC TGG CCG GAA AGT GTC TAC TTT TTT 
AAA CGC GGC GGC AGT ATT CAA CAA TAC ATC TAT AAA CAG GAG CCT 
GTC CAA AAA TGC CCT GGT CGT CGT CCG GCG CTG AAT TAT CCC GTG 
TAT GGA GAG ACA ACG CAG GTT CGC CGC CGT CGC TTC GAA CGC GCC 
ATC GGC CCG AGC CAA ACC CAC ACG ATT CGC ATT CAA TAT TCC CCA 
GCT CGT CTG GCG TAC CAG GAC AAA GGT GTG CTG CAC AAT GAA GTA 
AAA GTT AGC ATC CTG TGG CGT GGC CTG CCG AAT GTG GTG ACG TCT 
GCG ATC TCC CTC CCG AAT ATT CGC AAA CCC GAT GGT TAT GAT TAC 
TAT GCA TTC TCA AAA GAT CAG TAC TAT AAT ATC GAT GTC CCC TCC 
CGT ACA GCT CGT GCG ATC ACC ACT CGG TCA GGT CAA ACG CTG AGC 
AAG GTT TGG TAC AAT TGC CCA -3' 
 
Primary sequence of translated PRG4-PEX-domain "gene" polypeptide: 
 
1   PNQGIIINPMLSDETNICNGKPVDGLTTLRNGTLVAFRGHYFWMLSPFSP 50 
51  PSPARRITEVWGIPSPIDTVFTRCNCEGKTFFFKDSQYWRFTNDIKDAGY 100 
101 PKPIFKGFGGLTGQIVAALSTAKYKNWPESVYFFKRGGSIQQYIYKQEPV 150 
151 QKCPGRRPALNYPVYGETTQVRRRRFERAIGPSQTHTIRIQYSPARLAYQ 200 
201 DKGVLHNEVKVSILWRGLPNVVTSAISLPNIRKPDGYDYYAFSKDQYYNI 250 
251 DVPSRTARAITTRSGQTLSKVWYNCP 276 
 
Total length= 276 residues 
Molecular weight = 31.51 kDa 
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APPENDIX G 
 
Return of results from MU-DNA LIMS sequencing facility. Submission of sample from 
Colony 8 from PCR of transformed ligation products of the PRG4 PEX domain-pET-
44a construct: 
 
proteoglycan 4 isoform B preproprotein [Homo sapiens]  
Sequence ID: ref|NP_001121180.2|Length: 1363Number of Matches: 1 
Related Information 
Gene-associated gene details 
Map Viewer-aligned genomic context 
Range 1: 1088 to 1363GenPeptGraphics Next Match Previous Match  
 
 
Alignment statistics for match #1 
 
Score Expect Method Identities Positives Gaps 
629 bits 
(1622) 
0.0 
Compositional 
matrix adjust. 
276/276 
(100%) 
276/276 
(100%) 
0/276 
(0%) 
      
Query  1     PNQGIIINPMLSDETNICNGKPVDGLTTLRNGTLVAFRGHYFWMLSPFSPPSPARRITEV  60 
             PNQGIIINPMLSDETNICNGKPVDGLTTLRNGTLVAFRGHYFWMLSPFSPPSPARRITEV 
Sbjct  1088  PNQGIIINPMLSDETNICNGKPVDGLTTLRNGTLVAFRGHYFWMLSPFSPPSPARRITEV  1147 
 
Query  61    WGIPSPIDTVFTRCNCEGKTFFFKDSQYWRFTNDIKDAGYPKPIFKGFGGLTGQIVAALS  120 
             WGIPSPIDTVFTRCNCEGKTFFFKDSQYWRFTNDIKDAGYPKPIFKGFGGLTGQIVAALS 
Sbjct  1148  WGIPSPIDTVFTRCNCEGKTFFFKDSQYWRFTNDIKDAGYPKPIFKGFGGLTGQIVAALS  1207 
 
Query  121   TAKYKNWPESVYFFKRGGSIQQYIYKQEPVQKCPGRRPALNYPVYGETTQVRRRRFERAI  180 
             TAKYKNWPESVYFFKRGGSIQQYIYKQEPVQKCPGRRPALNYPVYGETTQVRRRRFERAI 
Sbjct  1208  TAKYKNWPESVYFFKRGGSIQQYIYKQEPVQKCPGRRPALNYPVYGETTQVRRRRFERAI  1267 
 
Query  181   GPSQTHTIRIQYSPARLAYQDKGVLHNEVKVSILWRGLPNVVTSAISLPNIRKPDGYDYY  240 
             GPSQTHTIRIQYSPARLAYQDKGVLHNEVKVSILWRGLPNVVTSAISLPNIRKPDGYDYY 
Sbjct  1268  GPSQTHTIRIQYSPARLAYQDKGVLHNEVKVSILWRGLPNVVTSAISLPNIRKPDGYDYY  1327 
 
Query  241   AFSKDQYYNIDVPSRTARAITTRSGQTLSKVWYNCP  276 
             AFSKDQYYNIDVPSRTARAITTRSGQTLSKVWYNCP 
Sbjct  1328  AFSKDQYYNIDVPSRTARAITTRSGQTLSKVWYNCP  1363 
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APPENDIX H 
ANALYSES FROM MASS SPECTROMETRY ON PRG4 PEX-DOMAIN 
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APPENDIX I 
SEQUENCE ALIGNMENTS FOR THE Atp1a3 PROTEIN IN PRIMATES ROOTED 
WITH MURINES 
Table A5. Sequence alignment of the Atp1a3 protein in mammals with an emphasis on 
Primates. The surprise phylogenetic split in the Great Apes is supported by numerous blocks 
of divergent non-synonymous residue substitutions that are consistent throughout the length 
of the proteins. The differential blocks for the "Human-Chimp" clade are highlighted in 
GREEN and for the "Bonobo-Gorilla" clade in RED. Site # indicates the beginning and end 
of the specific portions of the alignment presented. The entire alignment is 1031 sites in 
length 
 
 
SPECIES SITE # SEQUENCE SITE # 
Colobus 1 MGGWEEERNGRAKMGRLS--DKKDDKDSPKKNKGKERRDLDDLKKEVAM 49 
Chimp 1 MG-----SGGSDSYRIATSQDKKDDKDSPKKNKGKERRDLDDLKKEVAM 49 
Human 1 MG------------------DKKDDKDSPKKNKGKERRDLDDLKKEVAM 49 
Mangaby 1 MA-----R------------DKKDDKDSPKKNKGKERRDLDDLKKEVAM 49 
Bonobo 1 MG-----RGAGREYSPAA--TTAENGGGKKKQKEKE---LDELKKEVAM 49 
Gorilla 1 MG-----RGAGREYSPAA--TTAENGGGKKKQKEKE---LDELKKEVAM 49 
Orangutan 1 MG-----RGAGREYSPAA--TTAENGGGKKKQKEKE---LDELKKEVAM 49 
Baboon 1 MG-----RGAGREYSPAA--TTAENGGGKKKQKEKE---LDELKKEVAM 49 
Lemur 1 MG------------------DKKDDKGSPKKNKAKERRDLDDLKKEVAM 49 
Saimiri 1 MG------------------DKKDDKGSPKKNKGKERRDLDDLKKEVAM 49 
Aotus 1 MG------------------DKKDDKGSPKKNKGKERRDLDDLKKEVAM 49 
Rat 1 MG------------------DKKDDKSSPKKSKAKERRDLDDLKKEVAM 49 
Mouse 1 MG------------------DKKDDKSSPKKSKAKERRDLDDLKKEVAM 49 
 
 
 
 
 
 
SPECIES SITE # SEQUENCE SITE # 
Colobus 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Chimp 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Human 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Mangaby 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Bonobo 50 DDHKLSLDELGRKYQVDLSKGLTNQRAQDVLARDGPNALTPPPTTPEWV 98 
Gorilla 50 DDHKLSLDELGRKYQVDLSKGLTNQRAQDVLARDGPNALTPPPTTPEWV 98 
Orangutan 50 DDHKLSLDELGRKYQVDLSKGLTNQRAQDVLARDGPNALTPPPTTPEWV 98 
Baboon 50 DDHKLSLDELGRKYQVDLSKGLTNQRAQDVLARDGPNALTPPPTTPEWV 98 
Lemur 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Saimiri 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Aotus 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Rat 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
Mouse 50 TEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWV 98 
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SPECIES SITE # SEQUENCE SITE # 
Colobus 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Chimp 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Human 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Mangaby 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Bonobo 410 TTEDQSGATFDKRSPTWTALSRIAGLCNRAVFKAGQENISVSKRDTAGD 458 
Gorilla 410 TTEDQSGATFDKRSPTWTALSRIAGLCNRAVFKAGQENISVSKRDTAGD 458 
Orangutan 410 TTEDQSGATFDKRSPTWTALSRIAGLCNRAVFKAGQENISVSKRDTAGD 458 
Baboon 410 TTEDQSGATFDKRSPTWTALSRIAGLCNRAVFKAGQENISVSKRDTAGD 458 
Lemur 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Saimiri 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Aotus 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Rat 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
Mouse 410 TTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGD 458 
 
 
 
 
 
 
 
SPECIES SITE # SEQUENCE SITE # 
Colobus 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Chimp 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Human 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Mangaby 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Bonobo 466 KCIELSCGSVRKMRDRNPKVAEIPFNSTNKYQLSIHEREDSPQS-HVLV 514 
Gorilla 466 KCIELSCGSVRKMRDRNPKVAEIPFNSTNKYQLSIHEREDSPQS-HVLV 514 
Orangutan 466 KCIELSCGSVRKMRDRNPKVAEIPFNSTNKYQLSIHEREDSPQS-HVLV 514 
Baboon 466 KCIELSCGSVRKMRDRNPKVAEIPFNSTNKYQLSIHEREDSPQS-HVLV 514 
Lemur 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Saimiri 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Aotus 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Rat 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
Mouse 466 KCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLV 514 
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SPECIES SITE # SEQUENCE SITE # 
Colobus 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Chimp 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Human 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Mangaby 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Bonobo 550 YMELGGLGERVLGFCQLNLPSGKFPRGFKFDTDELNFPTEKLCFVGLMS 598 
Gorilla 550 YMELGGLGERVLGFCQLNLPSGKFPRGFKFDTDELNFPTEKLCFVGLMS 598 
Orangutan 550 YMELGGLGERVLGFCQLNLPSGKFPRGFKFDTDELNFPTEKLCFVGLMS 598 
Baboon 550 YMELGGLGERVLGFCQLNLPSGKFPRGFKFDTDELNFPTEKLCFVGLMS 598 
Lemur 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Saimiri 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Aotus 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Rat 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
Mouse 550 YLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMS 598 
 
 
. 
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APPENDIX J 
 
ACCESSION NUMBERS FOR ALL PROTEINS USED IN PHYLOGENETIC AND/OR 
STATISTICAL ANALYSES 
 
Table A6. Accession numbers for all protein sequences used, categorized by analyses. 
 
PROTEIN 
ACCESSION  
NUMBER 
PEX-Domain: 
Albumin_From_(Chickpea) PDB: 3S18_A 
Albumin-2_(Adzuki_bean) XP_017413862.1 
Albumin-2_(chickpea) NP_001296633.1 
Albumin-2_(Common_beet) XP_010671707.1 
Albumin-2_(Mung_bean) XP_014492280.1 
Albumin-2_(Adzuki_bean) XP_017411691.1 
Albumin-2_(Black_bean) ADR30065.1 
Albumin-2_(Rice) XP_015634475.1 
Albumin-2_(Barrel_medic) XP_003590505.1 
Albumin-2_(Common_beet) XP_010667439.1 
Albumin-2-like_isoX1_(Mung_bean) XP_014512929.1 
Albumin-2-like_isoX2_(Common_beet) XP_010692751.1 
Anther-specific_protein_(Garden_pea) AAM12036.1 
Chain_A_LS_24_(Grass_Pea) PDB: 3LP9_A 
HPX_(C)-dom_Homo AAA58678.1 
HPX_(N)-dom_Homo AAA58678.1 
HPX_C-dom_(little_skate) ADU15818.1 
HPX_C-dom_(nurse_shark) ADU15819.1 
Hpx_Fold_Protein_Cp4_(Cow_Pea) PDB: 3OYO_A 
HPX_N-dom_(little_skate) ADU15818.1 
HPX_N-dom_(nurse_shark) ADU15819.1 
Lectin_Cicer_(chickpea) AGL46982.1 
Limunectin_C-domain XP_013779174.1 
Limunectin_N-domain XP_013779174.1 
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MMP1_HPX_dom_Homo NP_002412.1 
MMP10_PEX_dom_Homo P09238.1 
MMP11_PEX_dom_Homo P24347.3 
MMP12_PEX_dom_Homo P39900.1 
MMP13_PEX_dom_Homo P45452.1 
MMP14_PEX_dom_Homo P50281.3 
MMP15_PEX_dom_Homo P51511.1 
MMP16_HPX_dom_Homo P51512.2 
MMP17_HPX_dom_Homo Q9ULZ9.4 
MMP19_HPX_dom_Homo Q99542.1 
MMP2_HPX_dom_Homo P08253.2 
MMP20_HPX_dom_Homo O60882.3 
MMP21_HPX_dom_Homo AAM78033.1 
MMP24_HPX_dom_Homo NP_006681.1 
MMP27_HPX_dom_Homo AAQ89112.1 
MMP3_HPX_dom_Homo NP_002413.1 
MMP8_HPX_dom_Homo P22894.1 
MMP9_PEX_dom_Homo P14780.3 
Ostreopexin_Pleurotus AHB89697.1 
P._luminescens_photopexin:_Prokayote OCA53183.1 
Photosystem_II_10_kDa(Bread_wheat) EMS53527.1 
Photosystem_II_10_kDa_(African_oil_palm) XP_010926934.1 
Photosystem_II_10_kDa_(Date_palm) XP_008799078.1 
Photosystem_II_10_kDa_(Tauschs_Goatgrass) XP_020201563.1 
Photosystem_II_PsbR_protein_(Formosa_lily) ACC38381.1 
PRG4_PEX_dom._Homo NP_001121180.2 
VTN_PEX_dom._Homo NP_000629.3 
WAP65-1_C-dom_(catfish) NP_001187177.1 
WAP65-1_N-dom_(catfish) NP_001187177.1 
WAP65-2_C-dom_(catfish) ABW07854.1 
WAP65-2_N-dom_(catfish) ABW07854.1 
JEN-14:  
Common Chimp HPX XP_508255.1 
Gorilla HPX XP_004050644.1 
Orangutan HPX CAI29597.1 
Gibbon HPX XP_003254905.1 
Mangabey HPX XP_011891896.1 
Pig HPX XP_020957866.1 
Cat HPX XP_003992978.1 
Rat HPX NP_445770.1 
Elephant HPX XP_006885694.1 
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Mouse HPX NP_059067.2 
Guinea pig HPX XP_003465366.2 
Nekid mole rat HPX XP_004863448.1 
Flying fox HPX XP_011383482.1 
Rabbit HPX NP_001076229.1 
Giant Panda HPX XP_019661247.1 
Short tailed opossum HPX XP_001380277.2 
Chicken HPX XP_015136422.1 
Alligator HPX XP_006037341.2 
European bass WAP1 DAA12504.1 
Atp1a3  
Human Atp1a3 NP_689509.1 
Common chimp Atp1a3 XP_016789718.1 
Bonobo Atp1a3 XP_003811938.1 
Gorilla Atp1a3 XP_004027126.1 
Orangutan Atp1a3 NP_001125304.1 
Olive baboon Atp1a3 XP_009182965.1 
Sooty mangabey Atp1a3 XP_011942294.1 
Colobus Atp1a3 XP_011791957.1 
Saimiri Atp1a3 XP_010329412.1 
Aotus Atp1a3 XP_012316962.1 
Lemur Atp1a3 XP_003799509.1 
Rat Atip1a3 NP_036638.1 
Mouse Atp1a3 EDL24296.1 
Macaque Atp1a3 NP_001253401.1 
DEAF1  
Human DEAF1 NP_066288.2 
Common chimp DEAF1 XP_016775505.1 
Bonobo DEAF1 XP_003805139.2 
Gorilla DEAF1 XP_018891300.1 
Orangutan DEAF1 XP_009244260.1 
Olive baboon DEAF1 XP_003909385.2 
Sooty mangabey DEAF1 XP_011896406.1 
Colobus DEAF1 XP_011785530.1 
Saimiri DEAF1 XP_010329533.1 
Aotus DEAF1 XP_012311445.1 
Lemur DEAF1 XP_012668771.1 
Rat DEAF1 NP_113989.2 
Mouse DEAF1 NP_058570.1 
Macaque DEAF1 XP_014968734.1 
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